{"gene":"MAP2","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1988,"finding":"The carboxyl-terminal domain of MAP2 containing three imperfect 18-amino acid repeats constitutes the microtubule binding site. A subcloned fragment spanning the first two repeats co-purified with microtubules through successive polymerization/depolymerization cycles, whereas the amino-terminal region failed to co-purify.","method":"In vitro translation of subcloned MAP2 fragments followed by microtubule co-purification (cycles of polymerization/depolymerization); complete cDNA sequencing","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with domain deletion mapping, foundational paper with 463 citations","pmids":["3142041"],"is_preprint":false},{"year":1988,"finding":"MAP2 mRNA is selectively localized in dendrites of developing brain neurons, whereas tubulin mRNA is restricted to neuronal cell bodies, demonstrating that dendritic targeting of MAP2 protein can occur via local dendritic mRNA translation.","method":"In situ hybridization with specific cDNA probes on developing brain tissue","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — direct localization experiment with functional implication, replicated across labs, 499 citations","pmids":["3200318"],"is_preprint":false},{"year":1984,"finding":"MAP2 is selectively localized to neuronal dendrites and dendritic spines (including postsynaptic densities), but is absent from axons, as demonstrated with monoclonal antibodies. MAP2 association with postsynaptic densities and spines suggests functions independent of microtubule binding.","method":"Immunocytochemistry with monoclonal hybridoma antibodies on brain tissue sections; immunoelectron microscopy","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — direct subcellular localization by immunoEM, replicated across multiple antibody clones, 342 citations","pmids":["6699682"],"is_preprint":false},{"year":1988,"finding":"MAP2 forms crossbridges between microtubules and neurofilaments in neuronal dendrites in vivo. Reconstitution experiments showed MAP2 binds neurofilament L protein in vitro and crosslinks neurofilaments with microtubules.","method":"Quick-freeze deep-etch immunoelectron microscopy with anti-MAP2 antibody and ferritin-labeled secondary; in vitro reconstitution with isolated neurofilament L protein and MAP2","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution combined with immunoEM in vivo validation, 172 citations","pmids":["3045269"],"is_preprint":false},{"year":1992,"finding":"MAP2 expression in non-neuronal fibroblasts via cDNA transfection stabilizes microtubules against depolymerizing reagents and promotes accumulation of acetylated alpha-tubulin, demonstrating that MAP2 directly confers microtubule stability in living cells.","method":"cDNA transfection of MAP2/MAP2c into fibroblasts; treatment with microtubule depolymerizing reagents; immunofluorescence for acetylated tubulin","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — clean gain-of-function in non-neuronal cells with orthogonal readouts (drug resistance + post-translational modification), 292 citations","pmids":["1487506"],"is_preprint":false},{"year":2002,"finding":"MAP2 is required for dendritic elongation and serves as an anchoring protein for the regulatory subunit II of cAMP-dependent protein kinase (PKA) in dendrites. MAP2-knockout mice show reduced microtubule density and dendritic length, reduced PKA subunits in dendrites, and impaired CREB phosphorylation after forskolin stimulation.","method":"MAP2-deficient (knockout) mice; microtubule density measurement; PKA subunit immunostaining and Western blot; phospho-CREB assay after forskolin stimulation in cultured neurons","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple orthogonal phenotypic readouts (morphology, biochemistry, signaling), 282 citations","pmids":["12163474"],"is_preprint":false},{"year":1990,"finding":"NMDA receptor activation induces rapid dephosphorylation (~70% decrease) of MAP2 in hippocampal slices without changing total MAP2 levels. The effect is blocked by NMDA antagonists and is distinct from non-NMDA receptor activation, suggesting calcium/calmodulin-dependent phosphatase (calcineurin) mediates NMDA-induced MAP2 dephosphorylation.","method":"32P-orthophosphate labeling of hippocampal slices; pharmacological dissection with competitive and non-competitive NMDA antagonists; SDS-PAGE phosphoprotein analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — clean pharmacological dissection with radiolabeled phosphate, replicated across brain regions, 202 citations","pmids":["2169265"],"is_preprint":false},{"year":1984,"finding":"Pre-phosphorylation of MAP2 by a co-purifying cAMP-independent protein kinase decreases MAP2 affinity for taxol-stabilized microtubules and increases the dissociation rate of microtubule polymerization in a phosphorylation level-dependent manner, demonstrating that MAP2 phosphorylation regulates microtubule binding and length.","method":"In vitro kinase phosphorylation of MAP2; microtubule binding assays with taxol-stabilized microtubules; polymerization kinetics measurements","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative in vitro reconstitution with dose-response phosphorylation, 118 citations","pmids":["6146522"],"is_preprint":false},{"year":1996,"finding":"Glutamate produces a biphasic regulation of MAP2 phosphorylation: rapid transient increase via metabotropic receptors (attenuated by CaMKII and PKC inhibitors), followed by persistent dephosphorylation via NMDA receptors and calcineurin (calcium/calmodulin-dependent phosphatase 2B). MAP2 phosphorylation state determines its interaction with microtubules and actin.","method":"32P-labeling of neurons; pharmacological dissection with glutamate receptor agonists/antagonists, CaMKII inhibitors, PKC inhibitors, calcineurin inhibitors; immunoprecipitation","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — bidirectional pharmacological dissection with radiolabeled phosphate, multiple kinase/phosphatase pathway assignments, 117 citations","pmids":["8789950"],"is_preprint":false},{"year":1990,"finding":"The repeated tubulin-binding sequence motif in both MAP2 and tau also mediates actin binding. A synthetic peptide corresponding to one of the repeated tubulin-binding sites binds G-actin by affinity chromatography and co-sediments with F-actin.","method":"Affinity chromatography of G-actin on synthetic peptide column; co-sedimentation of F-actin with peptide; immunoelectron microscopy co-localization","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical reconstitution with multiple orthogonal methods, 125 citations","pmids":["2115775"],"is_preprint":false},{"year":1999,"finding":"MAP2B (a high molecular weight MAP2 isoform) directly binds the alpha1 subunit of class C L-type Ca2+ channels and serves as an A-kinase anchor protein (AKAP) that recruits PKA to postsynaptic sites containing these channels. MAP2B association with channels is microtubule-independent.","method":"Immunoprecipitation from rat brain extracts; direct protein overlay binding assay with 32P-labeled RIIβ; immunoblotting; in vitro binding assay with purified channel alpha1 subunit; nocodazole treatment to rule out microtubule dependence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus in vitro direct binding assay, multiple orthogonal controls, 121 citations","pmids":["10514522"],"is_preprint":false},{"year":1999,"finding":"MARK kinases phosphorylate MAP2c (and MAP4) on their microtubule-binding domain in transfected CHO cells, causing detachment of MAP2 from microtubules, increased microtubule dynamic instability, and eventual microtubule disruption and vimentin network breakdown.","method":"Inducible expression of MARK1/MARK2 in CHO cells; immunofluorescence; microtubule stability assays; phosphorylation-state analysis","journal":"Cell motility and the cytoskeleton","confidence":"High","confidence_rationale":"Tier 2 — defined kinase expressed in cells with clear cytoskeletal phenotype and mechanistic follow-up, 127 citations","pmids":["10542369"],"is_preprint":false},{"year":1989,"finding":"High molecular weight MAP2 isoforms (MAP2a/b) contain a large N-terminal sidearm domain responsible for cross-linking dendritic microtubules and a dendritic targeting signal. The embryonic MAP2c isoform, generated by alternative splicing lacking 1,342 amino acids of the sidearm, has no dendritic mRNA targeting, indicating the targeting signal is specific to the high-molecular-weight forms.","method":"cDNA cloning and sequencing of MAP2 isoforms; in situ hybridization for MAP2c mRNA; electron microscopy of reconstituted microtubules","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — alternative splicing characterized with structural and localization data, 116 citations","pmids":["2770869"],"is_preprint":false},{"year":1993,"finding":"MAP2c-stabilized microtubule bundles in transfected non-neuronal cells support process outgrowth when actin is depolymerized by cytochalasin B. This effect is specific to MAP2c and does not occur with taxol-stabilized microtubules, demonstrating that MAP2c confers stability, bundling, and stiffness to microtubules—properties required for neurite-like process formation.","method":"MAP2c cDNA transfection into non-neuronal cells; cytochalasin B treatment; video time-lapse microscopy; comparison with taxol-treated controls","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — clean gain-of-function with specific pharmacological perturbation and live imaging, 110 citations","pmids":["8392463"],"is_preprint":false},{"year":2000,"finding":"cAMP-dependent protein kinase (PKA) activity disrupts the MAP2c-microtubule interaction in HeLa cells by phosphorylating serines within KXGS motifs (one per tubulin-binding repeat). Double or triple KXGS-to-glutamate mutations promote MAP2c redistribution to peripheral actin-enriched membrane ruffles, demonstrating phosphorylation-dependent switching between microtubule and actin cytoskeletal associations.","method":"PKA activation in HeLa cells expressing MAP2c; site-directed mutagenesis of KXGS motifs to glutamate (phosphomimetic); immunofluorescence and detergent extraction to assess cytoskeletal association; biochemical fractionation","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis combined with cell-based and biochemical assays, 106 citations","pmids":["11029056"],"is_preprint":false},{"year":1999,"finding":"A 640-nucleotide cis-acting dendritic targeting element (DTE) within the 3' UTR of MAP2 mRNA is both necessary and sufficient for dendritic localization of chimeric mRNAs in hippocampal and sympathetic neurons. The 5' UTR and coding region do not confer dendritic targeting.","method":"Chimeric mRNA reporter constructs transfected into hippocampal neurons and microinjected into sympathetic neurons; in situ hybridization to detect RNA distribution","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — necessity and sufficiency tested in two distinct neuronal cell types, 143 citations","pmids":["10516301"],"is_preprint":false},{"year":1997,"finding":"Phosphorylation of MAP2 by cdc2 kinase (7-10 mol phosphate/mol MAP2, >60% in microtubule-binding region) abolishes both microtubule-stabilizing and microtubule-nucleating activities. PKA phosphorylation (15 mol/mol, ~70% in projection region) reduces only microtubule-nucleating activity, not stabilizing activity. Direct observation of individual microtubules by dark-field microscopy revealed distinct mechanistic consequences.","method":"In vitro phosphorylation by purified PKA and cdc2 kinase; dark-field microscopy of individual microtubules; quantification of polymerization phases and nucleation","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with distinct kinases and direct single-microtubule visualization, 72 citations","pmids":["9376363"],"is_preprint":false},{"year":2000,"finding":"GSK3β phosphorylates MAP2c at Thr1620/Thr1623 (recognized by antibody 305) in co-transfected COS-1 cells, preventing microtubule bundle formation. Lithium chloride (GSK3 inhibitor) reverses this effect. Highly phosphorylated MAP2c species are enriched in cytoskeleton-unbound fractions.","method":"Co-transfection of MAP2c with wild-type or mutant GSK3β in COS-1 cells; lithium chloride inhibitor treatment; immunofluorescence for microtubule bundles; cytoskeletal fractionation; site-specific antibody staining","journal":"European journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — defined kinase co-expression with pharmacological rescue, 77 citations","pmids":["10826493"],"is_preprint":false},{"year":1992,"finding":"MAP2c reorganizes cellular microtubules into stable bundles independent of the microtubule-organizing center (MTOC) when expressed in non-neuronal cells. The bundles are stiff and long, with curvature only from cortical cytoskeleton constraint, demonstrating MAP2c imparts both stability and stiffness to microtubules.","method":"cDNA transfection of MAP2c into non-neuronal cell lines; immunofluorescence; comparison with taxol and DMSO treatment","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function in non-neuronal cells with mechanistic comparisons, 102 citations","pmids":["1338311"],"is_preprint":false},{"year":1989,"finding":"Biotin-labeled MAP2 microinjected into spinal cord neurons enters both axons and dendrites initially, but is selectively lost from axons over 3+ days. Immunoelectron microscopy shows axonal MAP2 is largely not cytoskeleton-associated, whereas dendritic MAP2 is cytoskeleton-bound, indicating differential cytoskeletal affinity (not sorting at cell body) underlies MAP2 compartmentalization.","method":"Microinjection of biotin-labeled MAP2 into cultured spinal cord neurons; immunoelectron microscopy; detergent extraction prior to immunocytochemistry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — direct protein tracking by microinjection with ultrastructural analysis, 61 citations","pmids":["2657741"],"is_preprint":false},{"year":1993,"finding":"MAP2C stabilizes microtubule bundles such that <10% of tubulin is exchanged within 1 hour (assessed by photoactivation of caged fluorescein-tubulin), yet exogenously introduced tubulin rapidly incorporates at distal bundle ends. This reveals that MAP2c-bundled microtubules are extremely stable internally while remaining capable of assembly at ends.","method":"Photoactivation of caged fluorescein-labeled tubulin in MAP2c-transfected fibroblasts; microinjection of biotin-labeled tubulin; immunofluorescence with anti-biotin","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — direct in vivo dynamic measurement by photoactivation, 61 citations","pmids":["8421058"],"is_preprint":false},{"year":2006,"finding":"The neurosteroid pregnenolone (PREG) and its analog MePREG bind directly to MAP2 and stimulate microtubule polymerization. RNAi knockdown of MAP2 abolishes the stimulatory effects of PREG/MePREG on neurite extension in NGF-treated PC12 cells but does not affect progesterone action, demonstrating MAP2 is the specific receptor for these neurosteroids.","method":"Neurite outgrowth assays in PC12 cells; RNA interference knockdown of MAP2; nocodazole protection assay; MAP2 immunostaining quantification","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with specific neurosteroid/receptor assignment, single lab","pmids":["16537405"],"is_preprint":false},{"year":2003,"finding":"DHEA binds specifically to the N-terminal region of MAP2c with an association constant of 2.7×10^7 M^-1 at 1:1 molar ratio, as measured by isothermal titration calorimetry. Tryptic digestion and mass spectrometry localized the binding site to the N-terminus. Structural modeling based on sequence homology with 17β-hydroxysteroid dehydrogenase 1 identified specific hydrogen bonds orienting DHEA in the binding pocket.","method":"Isothermal titration calorimetry; partial tryptic digestion; mass spectrometry; computational structural modeling","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1-2 — quantitative binding measurement with domain mapping, single lab, 47 citations","pmids":["12775713"],"is_preprint":false},{"year":1994,"finding":"ApoE3 but not ApoE4 binds MAP2c with high avidity (detectable down to 10^-9 M MAP2c and 10^-8 M apoE3), paralleling its differential binding to tau. This isoform-specific interaction suggests apoE genotype may affect intracellular microtubule maintenance via MAP2c binding.","method":"Direct binding assay between apoE isoforms and MAP2c; concentration-dependent binding analysis","journal":"Neuroscience letters","confidence":"Medium","confidence_rationale":"Tier 3 — single binding assay, single lab, but clear isoform specificity demonstrated","pmids":["7891887"],"is_preprint":false},{"year":1994,"finding":"MAP2 microtubule binding requires the repeat domain plus contiguous sequences on either side (particularly the proline-rich domain N-terminal to the repeats). Deletion mutant analysis shows binding strength increases with number of repeats present, and microtubule bundling and process outgrowth capacity correlate with binding strength.","method":"Series of deletion mutants of MAP2c transfected into non-neuronal cells; immunofluorescence for microtubule association and bundle formation; process outgrowth assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — systematic deletion mutagenesis with multiple functional readouts, 64 citations","pmids":["7699010"],"is_preprint":false},{"year":1994,"finding":"High-molecular-weight MAP2 binds phosphatidylinositol with high affinity (Kd ~51 nM) compared to MAP2c, tau, and recombinant human tau (~1.4-2.4 μM). The high affinity is due to two interactions: a low-affinity site in the C-terminal domain shared with MAP2c/tau, and a high-affinity site (Kd ~221 nM) in the MAP2-specific projection domain eliminated by alternative splicing in MAP2c.","method":"Binding to phosphatidylinositol and phosphatidylcholine vesicles; thrombin digestion of MAP2c; affinity measurements","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 — quantitative in vitro binding with domain-mapping using proteolytic fragments, single lab","pmids":["8025110"],"is_preprint":false},{"year":1996,"finding":"Juvenile MAP2c and mature (full-length) MAP2 induce distinct patterns of process outgrowth in Sf9 insect cells: MAP2c induces multiple short thin processes with closely-spaced microtubules, while mature MAP2 induces single thick processes with proximo-distal taper and decreasing microtubule number, establishing MAP2 isoforms as architectural determinants of process morphology.","method":"Baculovirus expression in Sf9 cells; electron microscopy of processes; measurement of microtubule spacing and number along processes","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 — comparative isoform expression with ultrastructural analysis, single lab","pmids":["8868472"],"is_preprint":false},{"year":1992,"finding":"MAP2 forms antiparallel dimers as shown by electron microscopy and antibody labeling. Intact MAP2 forms rod-like particles of ~97 nm. Major chymotryptic fragments map to a 36 kDa microtubule-binding fragment (~49 nm rods) and the AP18 antibody epitope maps to the first 151 residues; AP18 binding is phosphorylation-dependent.","method":"Limited proteolysis; electron microscopy; antibody epitope mapping; phosphorylation-dependent antibody binding assay","journal":"Journal of structural biology","confidence":"Medium","confidence_rationale":"Tier 2 — structural characterization with biochemical validation, single lab","pmids":["1373291"],"is_preprint":false},{"year":1997,"finding":"MAP2 phosphorylation at Ser136 (a Ser-Pro motif) in vivo and in vitro is catalyzed by proline-directed kinases (MAP kinase, GSK-3, cdk family members) but not by PKA, PKC, or CaMKII. This site is endogenously phosphorylated in brain MAP2. Microinjection of MAP2 into cells induces microtubule reorganization regardless of Ser136 phosphorylation state.","method":"Site-directed mutagenesis of Ser136; in vitro phosphorylation with multiple purified kinases; monoclonal antibody AP18 for phospho-specific detection; microinjection into cell lines","journal":"European journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — site-directed mutagenesis combined with in vitro kinase specificity panel and in vivo validation, 57 citations","pmids":["7525290"],"is_preprint":false},{"year":1983,"finding":"MAP2 binds to a poly(dA)4/poly(dT)4 sequence present in mouse satellite DNA (Sau96.1 restriction fragment). DNase protection assay showed MAP2 specifically protects this dA/dT sequence from digestion.","method":"Affinity binding of MAP2 to satellite DNA restriction fragments; DNase I protection assay","journal":"The EMBO journal","confidence":"Low","confidence_rationale":"Tier 3 — single biochemical assay, functional significance unclear, single lab","pmids":["10872313"],"is_preprint":false},{"year":2011,"finding":"MAP2 mRNA localizes to dendrites in distinct ribonucleoprotein particles (RNPs) containing very few RNA molecules per particle. The number of MAP2 mRNA molecules per RNP is regulated by synaptic activity and by Staufen 2, demonstrating that RNP composition controlling MAP2 mRNA transport is dynamically controlled.","method":"Single-molecule fluorescence in situ hybridization; Staufen 2 manipulation; synaptic activity modulation; quantitative RNP analysis","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 — direct quantitative single-molecule RNA visualization with functional manipulation, single lab","pmids":["21869818"],"is_preprint":false},{"year":2012,"finding":"L1CAM (L1 cell adhesion molecule) binds directly to MAP2c via ELISA, and promotes MAP2a/b/c expression through the MAPK pathway. L1-deficient mice show reduced MAP2c mRNA and protein. Co-immunoprecipitation shows MAP2a/b associates with L1 via intermediate partners. Combined L1 and MAP2 deficiency reduces neurite outgrowth.","method":"ELISA direct binding assay (MAP2c to intracellular domain of L1); co-immunoprecipitation; L1-deficient mouse brain analysis; MAPK pathway inhibition; neurite outgrowth assays","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct binding plus genetic mouse model, MAPK pathway pharmacological inhibition, single lab","pmids":["22503709"],"is_preprint":false},{"year":1995,"finding":"A MAP2-associated kinase (embryonic MAP2 kinase, Mr=100,000) co-purified with chicken embryonic MAP2 reverses MAP2-mediated inhibition of microtubule-based motor (kinesin/dynein) motility by phosphorylating MAP2 at serine residues and releasing it from microtubules. This kinase is cAMP-independent and distinct from cdc2, MAPK, bovine MAP2 kinase, and NIMA kinase.","method":"In vitro microtubule gliding motility assay; kinase co-purification; phosphorylation analysis; inhibitor profiling","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1-2 — in vitro functional reconstitution of motility rescue, single lab","pmids":["7759496"],"is_preprint":false},{"year":2003,"finding":"Deletion of the N-terminal 158 amino acids of MAP2 (which contains the PKA-RIIβ binding site) in mice results in decreased MAP2 phosphorylation efficiency, major changes in hippocampal neuron morphology, and selective impairment of contextual (but not auditory cue) fear memory, demonstrating that PKA anchoring to MAP2 is essential for contextual memory formation.","method":"Homologous recombination gene targeting (N-terminal deletion); immunohistochemistry; behavioral fear conditioning tests; biochemical phosphorylation analysis","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — precise genetic deletion of functional domain with behavioral, morphological and biochemical readouts, 51 citations","pmids":["12763072"],"is_preprint":false},{"year":2019,"finding":"NMR and cryo-EM analysis reveals that MAP2c and tau40 are intrinsically disordered but contain transient local structural motifs (molecular recognition elements) in free solution. These short sequence motifs exhibiting transient structure correspond to functional interaction sites, and their interactions are regulated by phosphorylation. MAP2c and tau40 adopt defined conformations when bound to microtubules and filamentous actin.","method":"Nuclear magnetic resonance (NMR) conformational analysis; cryo-electron microscopy; comparison of free vs. complex-bound conformations; phosphorylation state analysis","journal":"Biomolecules","confidence":"Medium","confidence_rationale":"Tier 1 — NMR structural analysis, but primarily comparative/descriptive rather than mechanistic functional validation","pmids":["30884818"],"is_preprint":false},{"year":2023,"finding":"MAP2 microtubule-binding domain fragments make microtubules more flexible (less straight) compared to tau-bound microtubules, as measured by teardrop pattern analysis in hydrodynamic flow. In SH-SY5Y cells, processes expressing MAP2 show more branching than tau-expressing processes. MAP2 differs from tau in imparting lower flexural rigidity to microtubules.","method":"Fluorescence microscopy of microtubules in hydrodynamic flow; teardrop pattern flexural rigidity analysis; transfection of MAP2/tau/MAP4 in SH-SY5Y cells; electron microscopy of processes","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1-2 — quantitative biophysical measurement combined with cell-based validation, single lab","pmids":["37258650"],"is_preprint":false},{"year":2020,"finding":"NCAM2 forms a protein complex with MAP2 and 14-3-3γ/ζ in neurons. NCAM2 depletion leads to destabilization of the microtubular network and reduced MAP2 signal, severe dendritic architecture defects, and impaired neuronal polarization both in vitro and in vivo.","method":"Proteomic analysis; co-immunoprecipitation; NCAM2 shRNA knockdown in hippocampal neurons; in utero electroporation for in vivo studies; immunofluorescence","journal":"Cerebral cortex","confidence":"Medium","confidence_rationale":"Tier 2-3 — proteomic interaction combined with loss-of-function in vitro and in vivo, but MAP2 role is inferred rather than directly tested","pmids":["32043120"],"is_preprint":false},{"year":2006,"finding":"TTLL7, a beta-tubulin polyglutamylase, is required for growth of MAP2-positive neurites. TTLL7 accumulates in the MAP2-enriched somatodendritic compartment, and RNAi knockdown of TTLL7 represses NGF-stimulated MAP2-positive neurite growth in PC12 cells while reducing polyglutamylated beta-tubulin.","method":"In vitro polyglutamylation assay with recombinant TTLL7; siRNA knockdown in PC12 and superior cervical ganglion neurons; immunofluorescence; Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro enzymatic assay combined with siRNA loss-of-function in neurons with specific neurite readout, 131 citations","pmids":["16901895"],"is_preprint":false}],"current_model":"MAP2 is a neuron-specific, dendritically localized microtubule-associated protein that promotes microtubule polymerization, nucleation, stabilization, and bundling through a C-terminal repeat-containing microtubule-binding domain; its affinity for microtubules is bidirectionally regulated by phosphorylation (PKA and cdc2 at KXGS and Ser-Pro motifs reduce binding, while calcineurin-mediated dephosphorylation via NMDA receptor activation promotes it), and in the phosphorylated state MAP2 redistributes to the actin cytoskeleton; MAP2 also functions as an A-kinase anchoring protein (AKAP) that recruits PKA-RIIβ to dendrites (required for proper cAMP/CREB signaling and contextual memory), directly binds the alpha1 subunit of L-type Ca2+ channels, serves as a receptor for neurosteroids (PREG, DHEA) at its N-terminus, cross-links microtubules to neurofilaments, and its mRNA is targeted to dendrites via a 640-nt cis-acting element in its 3' UTR."},"narrative":{"teleology":[{"year":1984,"claim":"Establishing MAP2 as a dendrite-specific cytoskeletal protein resolved the question of whether microtubule-associated proteins showed compartmental specificity in neurons, revealing MAP2 localizes to dendrites and postsynaptic densities but not axons.","evidence":"Immunocytochemistry and immunoelectron microscopy with monoclonal antibodies on brain tissue","pmids":["6699682"],"confidence":"High","gaps":["Mechanism of dendritic restriction unknown at this stage","Whether MAP2 has functions independent of microtubules at postsynaptic densities was unresolved"]},{"year":1984,"claim":"Demonstrating that phosphorylation reduces MAP2–microtubule affinity in a dose-dependent manner established phosphorylation as a regulatory switch for MAP2 function, opening the question of which kinases and phosphatases operate in vivo.","evidence":"In vitro phosphorylation by co-purifying kinase; taxol-stabilized microtubule binding and polymerization kinetics","pmids":["6146522"],"confidence":"High","gaps":["Identity of the endogenous kinase unknown","In vivo relevance not yet demonstrated"]},{"year":1988,"claim":"Mapping the microtubule-binding domain to the C-terminal 18-amino-acid repeats defined the minimal structural unit for MAP2–tubulin interaction and revealed domain architecture shared with tau.","evidence":"In vitro translation of MAP2 subcloned fragments followed by microtubule co-purification cycles; cDNA sequencing","pmids":["3142041"],"confidence":"High","gaps":["Whether flanking sequences contribute to binding strength was untested","Structural basis of repeat–tubulin contact unresolved"]},{"year":1988,"claim":"Discovery that MAP2 mRNA is dendritically localized provided a mechanism for dendritic MAP2 protein enrichment through local translation, complementing protein-level localization studies and raising the question of what cis-elements direct the mRNA.","evidence":"In situ hybridization with specific cDNA probes on developing brain tissue","pmids":["3200318"],"confidence":"High","gaps":["cis-acting targeting element not yet identified","Whether local translation is activity-regulated was unknown"]},{"year":1988,"claim":"Demonstrating that MAP2 cross-links microtubules to neurofilaments in dendrites expanded its role from microtubule stabilizer to an integrator of the dendritic cytoskeletal network.","evidence":"Quick-freeze deep-etch immunoEM in vivo; in vitro reconstitution with neurofilament L protein","pmids":["3045269"],"confidence":"High","gaps":["Binding site on neurofilament L not mapped","Regulation of cross-linking activity unknown"]},{"year":1989,"claim":"Identification of the MAP2c splice variant lacking 1,342 aa of the projection domain, and demonstration that high-molecular-weight MAP2a/b but not MAP2c mRNA is dendritically targeted, linked alternative splicing to both isoform-specific architecture and mRNA localization.","evidence":"cDNA cloning/sequencing; in situ hybridization for MAP2c mRNA; EM of reconstituted microtubules","pmids":["2770869"],"confidence":"High","gaps":["Developmental regulation of splicing switch uncharacterized","Projection domain contribution to inter-microtubule spacing not quantified"]},{"year":1989,"claim":"Microinjection tracking showed MAP2 protein enters both axons and dendrites but is selectively retained in dendrites via cytoskeletal binding, establishing differential retention rather than sorting as the compartmentalization mechanism.","evidence":"Microinjection of biotin-labeled MAP2 into spinal cord neurons; immunoEM with detergent extraction","pmids":["2657741"],"confidence":"High","gaps":["What makes dendritic microtubules preferentially bind MAP2 was not determined","Whether phosphorylation state influences compartmental retention was untested"]},{"year":1990,"claim":"The tubulin-binding repeats were shown to also bind actin, revealing MAP2 as a bifunctional cytoskeletal linker and raising the question of how microtubule versus actin association is regulated.","evidence":"Affinity chromatography of G-actin on synthetic peptide; F-actin co-sedimentation","pmids":["2115775"],"confidence":"High","gaps":["Whether microtubule and actin binding are mutually exclusive was unclear","In vivo significance of actin binding not demonstrated"]},{"year":1990,"claim":"NMDA receptor activation was shown to rapidly dephosphorylate MAP2 via calcineurin, linking synaptic activity to microtubule regulation and identifying the first physiological signal controlling MAP2 phosphorylation state.","evidence":"32P-orthophosphate labeling of hippocampal slices; NMDA antagonist pharmacology","pmids":["2169265"],"confidence":"High","gaps":["Specific phosphorylation sites dephosphorylated by calcineurin not mapped","Functional consequences for microtubule stability not directly measured"]},{"year":1992,"claim":"Gain-of-function expression in non-neuronal cells proved MAP2 is sufficient to stabilize microtubules against depolymerizing agents, bundle them independently of the MTOC, and impart structural stiffness—core functions for dendritic architecture.","evidence":"MAP2/MAP2c cDNA transfection into fibroblasts; drug resistance assays; acetylated tubulin staining; immunofluorescence","pmids":["1487506","1338311"],"confidence":"High","gaps":["How bundling is coordinated with other dendritic MAPs in vivo unknown","Whether MAP2 stiffness is modulated by post-translational modifications untested"]},{"year":1993,"claim":"Photoactivation studies revealed MAP2c-bundled microtubules have extremely low internal tubulin exchange yet retain assembly-competent ends, explaining how MAP2 preserves stable dendritic microtubule cores while permitting dynamic growth.","evidence":"Photoactivation of caged fluorescein-tubulin in MAP2c-transfected fibroblasts; biotin-tubulin microinjection","pmids":["8421058"],"confidence":"High","gaps":["Whether this dynamic end assembly is regulated by MAP2 phosphorylation was not tested"]},{"year":1994,"claim":"Systematic deletion mutagenesis established that efficient microtubule binding requires the repeat domain plus flanking proline-rich sequences, and that binding strength correlates with bundling capacity and process outgrowth.","evidence":"Series of MAP2c deletion mutants transfected into non-neuronal cells; immunofluorescence and process outgrowth assays","pmids":["7699010"],"confidence":"High","gaps":["Structural basis of flanking region contribution unresolved","Whether post-translational modifications of flanking regions modulate binding untested"]},{"year":1996,"claim":"Biphasic glutamate-dependent phosphoregulation was mapped: metabotropic receptors activate CaMKII/PKC to transiently phosphorylate MAP2, while NMDA receptors activate calcineurin for sustained dephosphorylation, establishing a synaptic activity-dependent phosphorylation code that switches MAP2 between microtubule and actin association.","evidence":"32P-labeling in neurons; pharmacological dissection with receptor agonists/antagonists and kinase/phosphatase inhibitors","pmids":["8789950"],"confidence":"High","gaps":["Specific phosphosites responsible for the actin switch not identified","Whether the biphasic response occurs at individual synapses unknown"]},{"year":1997,"claim":"Distinct kinase-specific functional consequences were resolved: cdc2 phosphorylation abolishes both stabilizing and nucleating activities, while PKA phosphorylation selectively eliminates nucleation without affecting stabilization, demonstrating that different phosphorylation patterns produce distinct functional outcomes.","evidence":"In vitro phosphorylation by purified PKA and cdc2; dark-field single-microtubule visualization","pmids":["9376363"],"confidence":"High","gaps":["In vivo relevance of cdc2-mediated MAP2 regulation in postmitotic neurons unclear","Combinatorial effects of multiple kinases untested"]},{"year":1999,"claim":"Identification of MAP2B as an AKAP that directly binds L-type Ca²⁺ channel α1 subunits and recruits PKA to postsynaptic sites revealed a scaffolding function independent of microtubule binding, expanding MAP2's role to signaling complex assembly.","evidence":"Reciprocal Co-IP from brain; direct protein overlay binding; nocodazole control for microtubule independence","pmids":["10514522"],"confidence":"High","gaps":["Whether channel-MAP2-PKA complex formation is activity-regulated unknown","Stoichiometry of the complex not determined"]},{"year":1999,"claim":"MARK kinases were identified as physiological kinases that phosphorylate KXGS motifs in the microtubule-binding domain, causing MAP2 detachment and microtubule destabilization in cells.","evidence":"Inducible MARK1/MARK2 expression in CHO cells; microtubule stability and immunofluorescence assays","pmids":["10542369"],"confidence":"High","gaps":["MARK regulation in neurons not addressed","Whether MARK acts on MAP2 at synapses unknown"]},{"year":1999,"claim":"A 640-nt cis-acting dendritic targeting element in the 3′ UTR was shown to be necessary and sufficient for MAP2 mRNA dendritic localization, resolving the long-standing question of what directs MAP2 mRNA to dendrites.","evidence":"Chimeric mRNA reporters in hippocampal and sympathetic neurons; in situ hybridization","pmids":["10516301"],"confidence":"High","gaps":["Trans-acting factors recognizing the DTE not identified","Whether the DTE is activity-regulated unknown"]},{"year":2000,"claim":"Phosphomimetic mutations at KXGS motifs demonstrated that phosphorylation actively redirects MAP2 from microtubules to actin-rich membrane ruffles, establishing the molecular basis for phosphorylation-dependent cytoskeletal switching.","evidence":"Site-directed KXGS-to-Glu mutagenesis in HeLa cells; immunofluorescence; biochemical fractionation","pmids":["11029056"],"confidence":"High","gaps":["Whether this switch occurs dynamically at synapses in neurons not shown","Actin-binding surface versus microtubule-binding surface overlap not structurally resolved"]},{"year":2002,"claim":"MAP2 knockout mice revealed essential roles in dendritic elongation, microtubule density maintenance, and PKA/CREB signaling in dendrites, establishing MAP2 as both a structural and signaling scaffold in vivo.","evidence":"MAP2-deficient mice; microtubule density measurement; PKA subunit and phospho-CREB assays in cultured neurons","pmids":["12163474"],"confidence":"High","gaps":["Behavioral consequences of full MAP2 knockout not reported in this study","Compensatory changes by tau or MAP1B not assessed"]},{"year":2003,"claim":"Targeted deletion of the N-terminal PKA-anchoring domain showed that MAP2's AKAP function is specifically required for contextual fear memory, dissociating the signaling role from microtubule stabilization in a behavioral paradigm.","evidence":"N-terminal deletion mice by homologous recombination; fear conditioning behavioral tests; phosphorylation analysis","pmids":["12763072"],"confidence":"High","gaps":["Downstream PKA substrates mediating contextual memory not identified","Whether other AKAPs compensate partially unknown"]},{"year":2003,"claim":"Quantitative binding of the neurosteroid DHEA to the MAP2c N-terminus (Ka ~2.7×10⁷ M⁻¹) identified MAP2 as a direct neurosteroid receptor, a function previously unrecognized for a cytoskeletal protein.","evidence":"Isothermal titration calorimetry; tryptic digestion and mass spectrometry domain mapping","pmids":["12775713"],"confidence":"Medium","gaps":["In vivo relevance of neurosteroid–MAP2 interaction not demonstrated in this study","Whether DHEA binding alters MAP2 microtubule affinity untested"]},{"year":2006,"claim":"RNAi knockdown confirmed MAP2 is required for pregnenolone-stimulated neurite extension, validating MAP2 as a functional neurosteroid receptor that couples steroid binding to microtubule polymerization and neurite growth.","evidence":"MAP2 RNAi in PC12 cells; neurite outgrowth with PREG/MePREG; nocodazole protection assay","pmids":["16537405"],"confidence":"Medium","gaps":["Binding site for PREG on MAP2 not mapped at residue resolution","Whether neurosteroid regulation of MAP2 occurs in vivo in adult brain unknown"]},{"year":2011,"claim":"Single-molecule RNA imaging revealed MAP2 mRNA travels in small ribonucleoprotein particles whose composition is regulated by synaptic activity and Staufen 2, linking activity-dependent translational control to MAP2 mRNA transport.","evidence":"Single-molecule FISH; Staufen 2 manipulation; synaptic activity modulation","pmids":["21869818"],"confidence":"Medium","gaps":["Whether Staufen 2 directly binds the MAP2 3′ UTR DTE not shown","Translational output from individual RNPs not measured"]},{"year":2019,"claim":"NMR and cryo-EM structural analysis established that MAP2c is intrinsically disordered in solution but adopts defined conformations upon microtubule and F-actin binding, with transient local structural motifs (molecular recognition elements) marking functional interaction sites.","evidence":"NMR conformational analysis; cryo-EM; comparison of free versus complex-bound states","pmids":["30884818"],"confidence":"Medium","gaps":["High-resolution structure of MAP2 bound to microtubules not achieved","How phosphorylation alters these transient structures at atomic resolution unresolved"]},{"year":2023,"claim":"Biophysical measurements revealed MAP2 makes microtubules more flexible than tau does, correlating with increased process branching in neuronal cells, providing a mechanical basis for MAP2's role in dendritic (branched) versus tau's role in axonal (linear) architecture.","evidence":"Fluorescence microscopy of microtubules in hydrodynamic flow; teardrop flexural rigidity analysis; SH-SY5Y transfection","pmids":["37258650"],"confidence":"Medium","gaps":["Whether flexibility differences arise from distinct binding geometries or stoichiometries not resolved","In vivo measurement of microtubule flexural rigidity in dendrites versus axons not performed"]},{"year":null,"claim":"A high-resolution structural model of full-length MAP2 bound to microtubules is lacking, and how the multiple regulatory phosphorylation inputs are integrated at individual synapses to dynamically control MAP2 cytoskeletal switching, AKAP scaffolding, and neurosteroid reception remains an open question.","evidence":"","pmids":[],"confidence":"High","gaps":["No atomic-resolution structure of MAP2–microtubule complex","Combinatorial phosphorylation code not decoded in vivo","Compensation between MAP2, tau, and MAP1B in dendritic function not systematically addressed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,4,9,13,14,18,24,34,35]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[3,4,13,18,26]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[5,10,33]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[25]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0,3,4,9,13,14,18,20,24,35]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,5,19]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,6,8,10,33]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2,5,33]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[4,18,26,35]}],"complexes":[],"partners":["PRKAR2B","CACNA1C","NEFL","MARK1","MARK2","GSK3B","NCAM2","L1CAM"],"other_free_text":[]},"mechanistic_narrative":"MAP2 is a neuron-enriched microtubule-associated protein that orchestrates dendritic cytoskeletal architecture by promoting microtubule polymerization, nucleation, stabilization, and bundling through a C-terminal repeat domain, while also cross-linking microtubules to neurofilaments and actin filaments [PMID:3142041, PMID:1487506, PMID:3045269, PMID:2115775]. Its microtubule-binding affinity is bidirectionally regulated by phosphorylation: cdc2, MARK, GSK3β, and PKA phosphorylation within or near the repeat domain detach MAP2 from microtubules and redirect it toward actin-rich compartments, whereas NMDA receptor–activated calcineurin-mediated dephosphorylation restores microtubule association [PMID:11029056, PMID:2169265, PMID:8789950, PMID:10542369]. Beyond cytoskeletal regulation, MAP2 functions as an A-kinase anchoring protein (AKAP) that recruits PKA-RIIβ to dendrites—required for cAMP/CREB signaling and contextual fear memory—and directly binds the α1 subunit of L-type Ca²⁺ channels independently of microtubules [PMID:12163474, PMID:12763072, PMID:10514522]. Its mRNA is targeted to dendrites via a 640-nucleotide cis-acting element in the 3′ UTR, enabling local translation, while high-molecular-weight isoforms (MAP2a/b) contain a projection domain that determines inter-microtubule spacing, dendritic morphology, and lipid binding absent from the embryonic MAP2c splice variant [PMID:10516301, PMID:2770869, PMID:8868472]."},"prefetch_data":{"uniprot":{"accession":"P11137","full_name":"Microtubule-associated protein 2","aliases":[],"length_aa":1827,"mass_kda":199.5,"function":"The exact function of MAP2 is unknown but MAPs may stabilize the microtubules against depolymerization. They also seem to have a stiffening effect on microtubules","subcellular_location":"Cytoplasm, cytoskeleton; Cell projection, dendrite","url":"https://www.uniprot.org/uniprotkb/P11137/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MAP2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MAP2","total_profiled":1310},"omim":[{"mim_id":"619435","title":"RITSCHER-SCHINZEL SYNDROME 4; RTSC4","url":"https://www.omim.org/entry/619435"},{"mim_id":"618813","title":"TUBULIN TYROSINE LIGASE-LIKE 7; TTLL7","url":"https://www.omim.org/entry/618813"},{"mim_id":"618646","title":"DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2; DMJDS2","url":"https://www.omim.org/entry/618646"},{"mim_id":"618468","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 76; DEE76","url":"https://www.omim.org/entry/618468"},{"mim_id":"617894","title":"TRANSMEMBRANE PROTEIN 50B; TMEM50B","url":"https://www.omim.org/entry/617894"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Primary cilium","reliability":"Additional"},{"location":"Primary cilium tip","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":259.5},{"tissue":"retina","ntpm":379.4}],"url":"https://www.proteinatlas.org/search/MAP2"},"hgnc":{"alias_symbol":["MAP2A","MAP2B","MAP2C"],"prev_symbol":[]},"alphafold":{"accession":"P11137","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P11137","model_url":"https://alphafold.ebi.ac.uk/files/AF-P11137-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P11137-F1-predicted_aligned_error_v6.png","plddt_mean":40.53},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MAP2","jax_strain_url":"https://www.jax.org/strain/search?query=MAP2"},"sequence":{"accession":"P11137","fasta_url":"https://rest.uniprot.org/uniprotkb/P11137.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P11137/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P11137"}},"corpus_meta":[{"pmid":"3200318","id":"PMC_3200318","title":"Selective localization of messenger RNA for cytoskeletal protein MAP2 in dendrites.","date":"1988","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3200318","citation_count":499,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3142041","id":"PMC_3142041","title":"Microtubule-associated protein MAP2 shares a microtubule binding motif with tau protein.","date":"1988","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/3142041","citation_count":463,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10704996","id":"PMC_10704996","title":"Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function.","date":"2000","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/10704996","citation_count":409,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6699682","id":"PMC_6699682","title":"Differential subcellular localization of tubulin and the microtubule-associated protein MAP2 in brain tissue as revealed by immunocytochemistry with monoclonal hybridoma antibodies.","date":"1984","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/6699682","citation_count":342,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2444675","id":"PMC_2444675","title":"MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum.","date":"1987","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/2444675","citation_count":318,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1484385","id":"PMC_1484385","title":"The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration.","date":"1992","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/1484385","citation_count":310,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2480963","id":"PMC_2480963","title":"The microtubule binding domain of microtubule-associated protein MAP1B contains a repeated sequence motif unrelated to that of MAP2 and tau.","date":"1989","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/2480963","citation_count":297,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1487506","id":"PMC_1487506","title":"Increased microtubule stability and alpha tubulin acetylation in cells transfected with microtubule-associated proteins MAP1B, MAP2 or tau.","date":"1992","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/1487506","citation_count":292,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1713721","id":"PMC_1713721","title":"Molecular characterization of microtubule-associated proteins tau and MAP2.","date":"1991","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/1713721","citation_count":286,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12163474","id":"PMC_12163474","title":"MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12163474","citation_count":282,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1961755","id":"PMC_1961755","title":"Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1961755","citation_count":211,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2169265","id":"PMC_2169265","title":"Activation of NMDA receptors induces rapid dephosphorylation of the cytoskeletal protein MAP2.","date":"1990","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/2169265","citation_count":202,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1323485","id":"PMC_1323485","title":"Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease.","date":"1992","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/1323485","citation_count":191,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7001466","id":"PMC_7001466","title":"Microtubule-associated proteins: a monoclonal antibody to MAP2 binds to differentiated neurons.","date":"1980","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7001466","citation_count":189,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6572937","id":"PMC_6572937","title":"Immunocytochemical localization of actin and microtubule-associated protein MAP2 in dendritic spines.","date":"1983","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/6572937","citation_count":186,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3045269","id":"PMC_3045269","title":"MAP2 is a component of crossbridges between microtubules and neurofilaments in the neuronal cytoskeleton: quick-freeze, deep-etch immunoelectron microscopy and reconstitution studies.","date":"1988","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/3045269","citation_count":172,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2509111","id":"PMC_2509111","title":"Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and Tau.","date":"1989","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/2509111","citation_count":149,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10516301","id":"PMC_10516301","title":"Identification of a cis-acting dendritic targeting element in MAP2 mRNAs.","date":"1999","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10516301","citation_count":143,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16901895","id":"PMC_16901895","title":"TTLL7 is a mammalian beta-tubulin polyglutamylase required for growth of MAP2-positive neurites.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16901895","citation_count":131,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1905296","id":"PMC_1905296","title":"Non-neuronal 210 x 10(3) Mr microtubule-associated protein (MAP4) contains a domain homologous to the microtubule-binding domains of neuronal MAP2 and tau.","date":"1991","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/1905296","citation_count":130,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10542369","id":"PMC_10542369","title":"Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells.","date":"1999","source":"Cell motility and the cytoskeleton","url":"https://pubmed.ncbi.nlm.nih.gov/10542369","citation_count":127,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2115775","id":"PMC_2115775","title":"The tubulin-binding sequence of brain microtubule-associated proteins, tau and MAP-2, is also involved in actin binding.","date":"1990","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/2115775","citation_count":125,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36187353","id":"PMC_36187353","title":"More than a marker: potential pathogenic functions of MAP2.","date":"2022","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36187353","citation_count":122,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10514522","id":"PMC_10514522","title":"The A-kinase anchor protein MAP2B and cAMP-dependent protein kinase are associated with class C L-type calcium channels in neurons.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10514522","citation_count":121,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6146522","id":"PMC_6146522","title":"The multiple phosphorylation of the microtubule-associated protein MAP2 controls the MAP2:tubulin interaction.","date":"1984","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6146522","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8789950","id":"PMC_8789950","title":"Postsynaptic mechanisms for bidirectional control of MAP2 phosphorylation by glutamate receptors.","date":"1996","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/8789950","citation_count":117,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2770869","id":"PMC_2770869","title":"Embryonic MAP2 lacks the cross-linking sidearm sequences and dendritic targeting signal of adult MAP2.","date":"1989","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2770869","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15964096","id":"PMC_15964096","title":"Altered expression of MAP-2, GAP-43, and synaptophysin in the hippocampus of rats with chronic cerebral hypoperfusion correlates with cognitive impairment.","date":"2005","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15964096","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8392463","id":"PMC_8392463","title":"Actin depolymerisation induces process formation on MAP2-transfected non-neuronal cells.","date":"1993","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8392463","citation_count":110,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11029056","id":"PMC_11029056","title":"Phosphorylation-dependent localization of microtubule-associated protein MAP2c to the actin cytoskeleton.","date":"2000","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/11029056","citation_count":106,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9082959","id":"PMC_9082959","title":"Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes.","date":"1997","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/9082959","citation_count":106,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3121794","id":"PMC_3121794","title":"A 70-kilodalton microtubule-associated protein (MAP2c), related to MAP2.","date":"1988","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3121794","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1338311","id":"PMC_1338311","title":"Reorganisation of the microtubular cytoskeleton by embryonic microtubule-associated protein 2 (MAP2c).","date":"1992","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1338311","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16537405","id":"PMC_16537405","title":"Microtubule-associated protein 2 (MAP2) is a neurosteroid receptor.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16537405","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2743390","id":"PMC_2743390","title":"Distribution of MAP2 in dendritic spines and its colocalization with actin. An immunogold electron-microscope study.","date":"1989","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/2743390","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2423532","id":"PMC_2423532","title":"Brain-specific expression of MAP2 detected using a cloned cDNA probe.","date":"1986","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/2423532","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21869818","id":"PMC_21869818","title":"Independent localization of MAP2, CaMKIIα and β-actin RNAs in low copy numbers.","date":"2011","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/21869818","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10479686","id":"PMC_10479686","title":"Lamina-specific synaptic activation causes domain-specific alterations in dendritic immunostaining for MAP2 and CAM kinase II.","date":"1999","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10479686","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2165097","id":"PMC_2165097","title":"CD-3-mediated activation of MAP-2 kinase can be modified by ligation of the CD4 receptor. Evidence for tyrosine phosphorylation during activation of this kinase.","date":"1990","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2165097","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10826493","id":"PMC_10826493","title":"GSK3beta-mediated phosphorylation of the microtubule-associated protein 2C (MAP2C) prevents microtubule bundling.","date":"2000","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10826493","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8965322","id":"PMC_8965322","title":"Diminished microtubule-associated protein 2 (MAP2) immunoreactivity following cortical impact brain injury.","date":"1996","source":"Journal of neurotrauma","url":"https://pubmed.ncbi.nlm.nih.gov/8965322","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9588626","id":"PMC_9588626","title":"Making sense of the multiple MAP-2 transcripts and their role in the neuron.","date":"1998","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/9588626","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9376363","id":"PMC_9376363","title":"Phosphorylation states of microtubule-associated protein 2 (MAP2) determine the regulatory role of MAP2 in microtubule dynamics.","date":"1997","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9376363","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7891887","id":"PMC_7891887","title":"Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease.","date":"1994","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/7891887","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6376120","id":"PMC_6376120","title":"Widespread occurrence of polypeptides related to neurotubule-associated proteins (MAP-1 and MAP-2) in non-neuronal cells and tissues.","date":"1984","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/6376120","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1765166","id":"PMC_1765166","title":"MAP2: a sensitive cross-linker and adjustable spacer in dendritic architecture.","date":"1991","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/1765166","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7699010","id":"PMC_7699010","title":"Sequence analysis of MAP2 function in living cells.","date":"1994","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/7699010","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6641705","id":"PMC_6641705","title":"Differential distribution of microtubule-associated proteins MAP-1 and MAP-2 in neurons of rat brain and association of MAP-1 with microtubules of neuroblastoma cells (clone N2A).","date":"1983","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/6641705","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8537643","id":"PMC_8537643","title":"Changes of MAP2 phosphorylation during brain development.","date":"1995","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/8537643","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8421058","id":"PMC_8421058","title":"Dynamics of microtubules bundled by microtubule associated protein 2C (MAP2C).","date":"1993","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/8421058","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2657741","id":"PMC_2657741","title":"Rapid turnover of microtubule-associated protein MAP2 in the axon revealed by microinjection of biotinylated MAP2 into cultured neurons.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2657741","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3524754","id":"PMC_3524754","title":"Ontogenesis of microtubule-associated protein 2 (MAP2) in embryonic mouse cortex.","date":"1986","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/3524754","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7525290","id":"PMC_7525290","title":"Phosphorylation of microtubule-associated proteins MAP2a,b and MAP2c at Ser136 by proline-directed kinases in vivo and in vitro.","date":"1994","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7525290","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28661486","id":"PMC_28661486","title":"The role of MAP2 kinases and p38 kinase in acute murine liver injury models.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/28661486","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17239543","id":"PMC_17239543","title":"Calcium-dependent NMDA-induced dendritic injury and MAP2 loss in acute hippocampal slices.","date":"2007","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17239543","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12505814","id":"PMC_12505814","title":"Distribution of microtubule-associated protein MAP2-immunoreactive interstitial neurons in the parahippocampal white matter in subjects with schizophrenia.","date":"2003","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12505814","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12763072","id":"PMC_12763072","title":"Deletion of the N-terminus of murine map2 by gene targeting disrupts hippocampal ca1 neuron architecture and alters contextual memory.","date":"2003","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12763072","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1373291","id":"PMC_1373291","title":"Domain structure and antiparallel dimers of microtubule-associated protein 2 (MAP2).","date":"1992","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/1373291","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3502994","id":"PMC_3502994","title":"Developmental regulation of two microtubule-associated proteins (MAP2 and MAP5) in the embryonic avian retina.","date":"1987","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/3502994","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9051273","id":"PMC_9051273","title":"Co-expression of MAP-2 and GFAP in cells developing from rat EGF responsive precursor cells.","date":"1997","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9051273","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30884818","id":"PMC_30884818","title":"Structure and Functions of Microtubule Associated Proteins Tau and MAP2c: Similarities and Differences.","date":"2019","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/30884818","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15367708","id":"PMC_15367708","title":"Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs.","date":"2004","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/15367708","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3143928","id":"PMC_3143928","title":"Phylogenetic conservation of brain microtubule-associated proteins MAP2 and tau.","date":"1988","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/3143928","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10872313","id":"PMC_10872313","title":"Microtubule-associated protein MAP2 preferentially binds to a dA/dT sequence present in mouse satellite DNA.","date":"1983","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10872313","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7950310","id":"PMC_7950310","title":"Passive avoidance training induces enhanced levels of immunoreactivity for muscarinic acetylcholine receptor and coexpressed PKC gamma and MAP-2 in rat cortical neurons.","date":"1994","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/7950310","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8847742","id":"PMC_8847742","title":"Microtubule-associated proteins in developing oligodendrocytes: transient expression of a MAP2c isoform in oligodendrocyte precursors.","date":"1995","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/8847742","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12775713","id":"PMC_12775713","title":"Specific binding of dehydroepiandrosterone to the N terminus of the microtubule-associated protein MAP2.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12775713","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8618422","id":"PMC_8618422","title":"Microtubule-associated protein 2 (MAP-2): a sensitive marker of seizure-related brain damage.","date":"1995","source":"Journal of neuroscience methods","url":"https://pubmed.ncbi.nlm.nih.gov/8618422","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11457938","id":"PMC_11457938","title":"Distribution of map2 in hippocampus and cerebellum of young and old rats by quantitative immunohistochemistry.","date":"2001","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/11457938","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27143585","id":"PMC_27143585","title":"Spatiotemporal profile of Map2 and microglial changes in the hippocampal CA1 region following pilocarpine-induced status epilepticus.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27143585","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3712008","id":"PMC_3712008","title":"Microtubule-associated protein 2 (MAP2) is present in astrocytes of the optic nerve but absent from astrocytes of the optic tract.","date":"1986","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/3712008","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10336255","id":"PMC_10336255","title":"Developmental regulation of alternatively spliced isoforms of mRNA encoding MAP2 and tau in rat brain oligodendrocytes during culture maturation.","date":"1999","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/10336255","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8769894","id":"PMC_8769894","title":"MAP2a, an alternatively spliced variant of microtubule-associated protein 2.","date":"1996","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8769894","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2026175","id":"PMC_2026175","title":"Regulation of microtubule associated protein 2 (MAP2) expression by nerve growth factor in PC12 cells.","date":"1991","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/2026175","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8612323","id":"PMC_8612323","title":"Developmental regulation of MAP2 variants during neuronal differentiation in vitro.","date":"1995","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/8612323","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10708340","id":"PMC_10708340","title":"Increased dendritic MAP2 expression in the hippocampus in schizophrenia.","date":"2000","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/10708340","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9786247","id":"PMC_9786247","title":"Neuropil threads are collinear with MAP2 immunostaining in neuronal dendrites of Alzheimer brain.","date":"1998","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9786247","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9391014","id":"PMC_9391014","title":"Experience-dependent modifications in MAP2 phosphorylation in rat olfactory bulb.","date":"1997","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9391014","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8369956","id":"PMC_8369956","title":"Acute anoxia-induced alterations in MAP2 immunoreactivity and neuronal morphology in rat hippocampus.","date":"1993","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/8369956","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9372295","id":"PMC_9372295","title":"Neuronal damage and MAP2 changes induced by the glutamate transport inhibitor dihydrokainate and by kainate in rat hippocampus in vivo.","date":"1997","source":"Experimental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9372295","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22503709","id":"PMC_22503709","title":"L1CAM increases MAP2 expression via the MAPK pathway to promote neurite outgrowth.","date":"2012","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/22503709","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8868472","id":"PMC_8868472","title":"Juvenile and mature MAP2 isoforms induce distinct patterns of process outgrowth.","date":"1996","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/8868472","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11397138","id":"PMC_11397138","title":"A computational model of dendrite elongation and branching based on MAP2 phosphorylation.","date":"2001","source":"Journal of theoretical biology","url":"https://pubmed.ncbi.nlm.nih.gov/11397138","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9178955","id":"PMC_9178955","title":"Age-dependent organotypic expression of microtubule-associated proteins (MAP1, MAP2, and MAP5) in rat brain.","date":"1997","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/9178955","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8025110","id":"PMC_8025110","title":"The difference in the binding of phosphatidylinositol distinguishes MAP2 from MAP2C and Tau.","date":"1994","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8025110","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7759496","id":"PMC_7759496","title":"A microtubule-associated protein (MAP2) kinase restores microtubule motility in embryonic brain.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7759496","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39230905","id":"PMC_39230905","title":"Diagnostic Performance of GFAP, UCH-L1, and MAP-2 Within 30 and 60 Minutes of Traumatic Brain Injury.","date":"2024","source":"JAMA network open","url":"https://pubmed.ncbi.nlm.nih.gov/39230905","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16328528","id":"PMC_16328528","title":"Microtubule-associated protein 2 (MAP2)--a promising approach to diagnosis of forensic types of hypoxia-ischemia.","date":"2005","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/16328528","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3719328","id":"PMC_3719328","title":"Calcium and calmodulin stimulated in vitro phosphorylation of rooster brain tubulin and MAP-2 following a single oral dose of tri-o-cresyl phosphate.","date":"1986","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/3719328","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8627364","id":"PMC_8627364","title":"Transgenic expression of embryonic MAP2 in adult mouse brain: implications for neuronal polarization.","date":"1996","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8627364","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16916793","id":"PMC_16916793","title":"Transcriptional regulation of human MAP2 gene in melanoma: role of neuronal bHLH factors and Notch1 signaling.","date":"2006","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/16916793","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19880519","id":"PMC_19880519","title":"Oncogenic BRAFV600E induces expression of neuronal differentiation marker MAP2 in melanoma cells by promoter demethylation and down-regulation of transcription repressor HES1.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19880519","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9930890","id":"PMC_9930890","title":"Immunohistochemical analysis of spinal cord lesions in amyotrophic lateral sclerosis using microtubule-associated protein 2 (MAP2) antibodies.","date":"1999","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/9930890","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29480405","id":"PMC_29480405","title":"miR-484/MAP2/c-Myc-positive regulatory loop in glioma promotes tumor-initiating properties through ERK1/2 signaling.","date":"2018","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/29480405","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32043120","id":"PMC_32043120","title":"NCAM2 Regulates Dendritic and Axonal Differentiation through the Cytoskeletal Proteins MAP2 and 14-3-3.","date":"2020","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/32043120","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37258650","id":"PMC_37258650","title":"Effects of three microtubule-associated proteins (MAP2, MAP4, and Tau) on microtubules' physical properties and neurite morphology.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37258650","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1375231","id":"PMC_1375231","title":"The juvenile microtubule-associated protein MAP2c is a rod-like molecule that forms antiparallel dimers.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1375231","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22874672","id":"PMC_22874672","title":"Dysfunction of microtubule-associated proteins of MAP2/tau family in Prion disease.","date":"2012","source":"Prion","url":"https://pubmed.ncbi.nlm.nih.gov/22874672","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2484443","id":"PMC_2484443","title":"Regulation of microtubule-associated protein 2 (MAP2) mRNA expression during rat brain development.","date":"1989","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/2484443","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33931805","id":"PMC_33931805","title":"The Cytoskeletal Elements MAP2 and NF-L Show Substantial Alterations in Different Stroke Models While Elevated Serum Levels Highlight Especially MAP2 as a Sensitive Biomarker in Stroke Patients.","date":"2021","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/33931805","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9087411","id":"PMC_9087411","title":"A second serine protease associated with mannan-binding lectin that activates complement.","date":"1997","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9087411","citation_count":667,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10639434","id":"PMC_10639434","title":"Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition.","date":"2000","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10639434","citation_count":442,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28319085","id":"PMC_28319085","title":"Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.","date":"2017","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28319085","citation_count":378,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10679061","id":"PMC_10679061","title":"Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10679061","citation_count":251,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10946292","id":"PMC_10946292","title":"Proteolytic activities of two types of mannose-binding lectin-associated serine protease.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10946292","citation_count":232,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11532276","id":"PMC_11532276","title":"The mannan-binding lectin pathway of complement activation: biology and disease association.","date":"2001","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11532276","citation_count":230,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16116205","id":"PMC_16116205","title":"Human M-ficolin is a secretory protein that activates the lectin complement pathway.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16116205","citation_count":205,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12904520","id":"PMC_12904520","title":"Inherited deficiency of mannan-binding lectin-associated serine protease 2.","date":"2003","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12904520","citation_count":184,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18849076","id":"PMC_18849076","title":"Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.","date":"2008","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18849076","citation_count":176,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12538697","id":"PMC_12538697","title":"Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12538697","citation_count":173,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22691502","id":"PMC_22691502","title":"Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22691502","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17215869","id":"PMC_17215869","title":"Structural insights into the innate immune recognition specificities of L- and H-ficolins.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17215869","citation_count":163,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11907111","id":"PMC_11907111","title":"Activation of the lectin complement pathway by H-ficolin (Hakata antigen).","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11907111","citation_count":160,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8538770","id":"PMC_8538770","title":"The reaction mechanism of the internal thioester in the human complement component C4.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8538770","citation_count":147,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10925294","id":"PMC_10925294","title":"Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10925294","citation_count":145,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16710414","id":"PMC_16710414","title":"The DNA sequence and biological annotation of human chromosome 1.","date":"2006","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16710414","citation_count":144,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10092804","id":"PMC_10092804","title":"Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10092804","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10330290","id":"PMC_10330290","title":"A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway.","date":"1999","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10330290","citation_count":140,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18842294","id":"PMC_18842294","title":"Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study.","date":"2008","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18842294","citation_count":138,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23533145","id":"PMC_23533145","title":"In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.","date":"2013","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23533145","citation_count":138,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8018603","id":"PMC_8018603","title":"Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein.","date":"1994","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8018603","citation_count":132,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23376485","id":"PMC_23376485","title":"Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.","date":"2013","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23376485","citation_count":126,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11527969","id":"PMC_11527969","title":"Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11527969","citation_count":125,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20002787","id":"PMC_20002787","title":"Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot.","date":"2009","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20002787","citation_count":125,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22966085","id":"PMC_22966085","title":"Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22966085","citation_count":116,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46422,"output_tokens":8118,"usd":0.130518},"stage2":{"model":"claude-opus-4-6","input_tokens":11953,"output_tokens":5087,"usd":0.28041},"total_usd":0.870448,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":59576,"output_tokens":9575,"usd":0.161177},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":13249,"output_tokens":5306,"usd":0.298343}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"The carboxyl-terminal domain of MAP2 containing three imperfect 18-amino acid repeats constitutes the microtubule binding site; a subcloned fragment spanning the first two repeats copurified with microtubules through successive cycles of polymerization and depolymerization, whereas an amino-terminal control fragment completely failed to copurify.\",\n      \"method\": \"In vitro translation of subcloned fragments + microtubule co-purification assay (cycling)\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with defined domain fragments, replicated conceptually across multiple labs\",\n      \"pmids\": [\"3142041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"MAP2 mRNA is selectively localized in dendrites of developing brain neurons, whereas tubulin mRNA is restricted to neuronal cell bodies, establishing dendritic targeting of MAP2 mRNA as a mechanism for local dendritic protein synthesis.\",\n      \"method\": \"In situ hybridization with cDNA probes in developing brain tissue\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in situ hybridization localization, foundational discovery replicated extensively\",\n      \"pmids\": [\"3200318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1984,\n      \"finding\": \"MAP2 is selectively localized to dendritic microtubules and postsynaptic densities (including dendritic spines), but is absent from axonal processes, establishing its somatodendritic compartmentalization by immunocytochemistry with monoclonal antibodies.\",\n      \"method\": \"Immunocytochemistry with monoclonal antibodies (AP9, AP13) on brain sections and electron microscopy\",\n      \"journal\": \"The Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by immunoEM, replicated across multiple labs\",\n      \"pmids\": [\"6699682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"MAP2 forms crossbridges between microtubules and neurofilaments in neuronal dendrites in vivo; reconstitution experiments demonstrated that MAP2 binds neurofilament L protein in vitro and crosslinks neurofilaments to microtubules.\",\n      \"method\": \"Quick-freeze deep-etch immunoelectron microscopy with anti-MAP2 antibody + in vitro reconstitution (SDS-PAGE and electron microscopy of pellets)\",\n      \"journal\": \"The Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution plus in vivo immunoEM, strong mechanistic evidence\",\n      \"pmids\": [\"3045269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"NMDA receptor activation induces rapid (~70%) dephosphorylation of MAP2 in hippocampal slices via stimulation of a protein phosphatase (likely calcineurin), without changing total MAP2 protein levels.\",\n      \"method\": \"32P-orthophosphate labeling of hippocampal slices, NMDA treatment with competitive and non-competitive antagonists\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with specific antagonists, direct phosphorylation measurement\",\n      \"pmids\": [\"2169265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1984,\n      \"finding\": \"Pre-phosphorylation of MAP2 by a co-purifying cAMP-independent kinase decreases its affinity for taxol-stabilized microtubules, increases the dissociation rate constant for microtubule polymerization, and causes immediate depolymerization of pre-assembled microtubules in a phosphorylation level-dependent manner.\",\n      \"method\": \"In vitro phosphorylation assay + microtubule binding/assembly kinetics\",\n      \"journal\": \"European Journal of Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution with kinetic measurements\",\n      \"pmids\": [\"6146522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"MAP2 anchors the regulatory subunit II of cAMP-dependent protein kinase (PKA) in dendrites; MAP2-deficient mice show reduced microtubule density and dendritic length, significant reduction of PKA subunits in dendrites, and impaired CREB phosphorylation after forskolin stimulation.\",\n      \"method\": \"MAP2 knockout mice, immunofluorescence, Western blot, PKA subunit localization, CREB phosphorylation assay in cultured neurons\",\n      \"journal\": \"The Journal of Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic knockout with multiple defined cellular and biochemical phenotypes\",\n      \"pmids\": [\"12163474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"MAP2c transfection into non-neuronal fibroblasts stabilizes microtubules, induces MTOC-independent microtubule bundle formation, and imparts stiffness to microtubules; these properties support process outgrowth when actin is depolymerized.\",\n      \"method\": \"cDNA transfection into non-neuronal cells, immunofluorescence, taxol/DMSO comparison\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function transfection with defined phenotypic readouts, replicated\",\n      \"pmids\": [\"1338311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Actin depolymerization with cytochalasin B in MAP2c-transfected non-neuronal cells induces outgrowth of microtubule-containing processes, demonstrating that MAP2c-stabilized microtubule bundles exert compressive forces that drive process outgrowth when counterbalanced by cortical actin tension.\",\n      \"method\": \"MAP2c cDNA transfection + cytochalasin B treatment, video time-lapse microscopy\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct manipulation with specific pharmacological agent, live imaging of process outgrowth\",\n      \"pmids\": [\"8392463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Glutamate produces bidirectional control of MAP2 phosphorylation: a rapid increase mediated by metabotropic receptors via calcium/calmodulin-dependent protein kinases and PKC, followed by persistent dephosphorylation mediated by NMDA receptors via calcineurin (phosphatase 2B).\",\n      \"method\": \"Phosphorylation assays in hippocampal neurons with pharmacological inhibitors of specific kinases and phosphatases\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal pharmacological approaches, mechanistic pathway dissection\",\n      \"pmids\": [\"8789950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A 640-nucleotide cis-acting element in the 3' UTR of MAP2 mRNA is both sufficient and essential for dendritic targeting of chimeric mRNAs in hippocampal and sympathetic neurons.\",\n      \"method\": \"Transfection/microinjection of chimeric reporter mRNAs with MAP2 3' UTR deletions in primary neurons\",\n      \"journal\": \"The Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — deletion mapping with chimeric constructs in two distinct neuronal cell types\",\n      \"pmids\": [\"10516301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"High molecular weight MAP2 (MAP2a/b) contains a long amino-terminal sidearm domain that crosslinks dendritic microtubules and a dendritic mRNA targeting signal, both absent from the embryonic MAP2c isoform, which is generated by alternative splicing removing 1,342 amino acids from the sidearm domain.\",\n      \"method\": \"Alternative splicing analysis of cDNA clones + in situ hybridization showing MAP2c mRNA is not present in dendrites\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — molecular characterization plus in situ hybridization localization, clear structure-function relationship\",\n      \"pmids\": [\"2770869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"The tubulin-binding repeat sequence common to MAP2 and tau also mediates actin binding; affinity chromatography of G-actin on a peptide column and co-sedimentation/immunoelectron microscopy of F-actin with the synthetic repeat peptide demonstrated the dual binding capacity.\",\n      \"method\": \"Affinity chromatography, co-sedimentation assay, immunoelectron microscopy with synthetic peptide corresponding to MAP2/tau tubulin-binding repeat\",\n      \"journal\": \"The Biochemical Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution with multiple complementary methods\",\n      \"pmids\": [\"2115775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MARK kinases phosphorylate MAP2c on KXGS motifs within the microtubule-binding domain in transfected CHO cells, causing detachment of MAP2 from microtubules and increased microtubule dynamic instability leading to microtubule disruption.\",\n      \"method\": \"Transfection of MAP2c and MARK kinases in CHO cells with inducible promoter system, immunofluorescence, and biochemical analysis\",\n      \"journal\": \"Cell Motility and the Cytoskeleton\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function in cells with defined phosphorylation sites, clear cellular phenotype\",\n      \"pmids\": [\"10542369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"PKA-mediated phosphorylation of serines within KXGS motifs in MAP2c's three tubulin-binding repeats disrupts the MAP2-microtubule interaction in living HeLa cells and promotes MAP2c relocalization to peripheral membrane ruffles enriched in actin; double/triple KXGS→KEGS mutations mimic constitutive phosphorylation and promote MAP2c-actin cytoskeleton association.\",\n      \"method\": \"Site-directed mutagenesis of KXGS motifs, transfection in HeLa cells, PKA activation, immunofluorescence, detergent extraction assay\",\n      \"journal\": \"Molecular Biology of the Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis combined with biochemical and imaging assays in living cells\",\n      \"pmids\": [\"11029056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"cdc2 kinase-dependent phosphorylation of MAP2 inhibits both its microtubule-stabilizing and microtubule-nucleating activities (reducing microtubule half-life to levels seen without MAP2), while PKA-dependent phosphorylation affects only microtubule-nucleating activity, demonstrating kinase-specific functional regulation.\",\n      \"method\": \"In vitro phosphorylation by PKA or cyclin B-cdc2 kinase, dark-field microscopy of individual microtubules, microtubule polymerization assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with two distinct kinases and direct single-microtubule visualization\",\n      \"pmids\": [\"9376363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GSK3β phosphorylates MAP2c in co-transfected COS-1 cells at the Thr1620/Thr1623 site (antibody 305 epitope), preventing microtubule bundle formation; lithium chloride (GSK3 inhibitor) reverses this effect, and phosphorylated MAP2c species are enriched in cytoskeleton-unbound fractions.\",\n      \"method\": \"Co-transfection of MAP2c with wild-type or mutant GSK3β in COS-1 cells, immunofluorescence, biochemical fractionation, lithium chloride inhibition\",\n      \"journal\": \"European Journal of Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function co-transfection with pharmacological rescue, defined phosphorylation site\",\n      \"pmids\": [\"10826493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MAP2B (a high molecular weight MAP2 isoform functioning as an AKAP) directly binds to the alpha1 subunit of class C L-type Ca2+ channels and anchors PKA to these channels at postsynaptic sites in neurons; this association is independent of microtubules.\",\n      \"method\": \"Immunoprecipitation of class C channels from rat brain, 32P-RIIβ overlay assay, immunoblotting, in vitro direct binding assay, nocodazole treatment\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus direct in vitro binding assay\",\n      \"pmids\": [\"10514522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Microinjected MAP2 distributes into both dendrites and axons initially, but axonal MAP2 undergoes rapid turnover (selective loss over 3+ days) because a large fraction of axonal MAP2 is not associated with the cytoskeleton, while dendritic MAP2 is cytoskeleton-associated; this differential cytoskeletal association underlies MAP2 compartmentalization rather than a sorting mechanism.\",\n      \"method\": \"Microinjection of biotin-labeled MAP2 into cultured spinal cord neurons, immunoelectron microscopy, detergent extraction followed by immunocytochemistry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the USA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct microinjection experiment with biochemical and ultrastructural analysis\",\n      \"pmids\": [\"2657741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Expression of MAP2c or tau in fibroblasts by cDNA transfection produces microtubule bundles enriched in acetylated alpha-tubulin that are resistant to microtubule-depolymerizing agents, demonstrating that MAP2c stabilizes microtubules and induces post-translational modification of tubulin.\",\n      \"method\": \"cDNA transfection of fibroblasts with MAP2c or tau, cold/drug depolymerization resistance assay, anti-acetylated tubulin immunofluorescence\",\n      \"journal\": \"Journal of Cell Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function transfection with multiple phenotypic readouts\",\n      \"pmids\": [\"1487506\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"MAP2 binds phosphatidylinositol with high affinity (Kd ~51 nM) through two sites: a low-affinity site in the C-terminal domain shared with MAP2c and tau (~1.5-2.5 μM Kd for anionic phospholipids), and a high-affinity site (Kd ~221 nM) in the MAP2-specific peptide absent from MAP2c due to alternative splicing.\",\n      \"method\": \"Lipid vesicle binding assays (Kd determination), comparison of MAP2, MAP2c, tau, and thrombin-digested MAP2c\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro binding assay with domain mapping via splicing variants and proteolysis\",\n      \"pmids\": [\"8025110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The neurosteroid pregnenolone (PREG) and its analog MePREG bind directly to MAP2 and stimulate microtubule polymerization; siRNA knockdown of MAP2 blocks PREG/MePREG-stimulated neurite outgrowth in NGF-pretreated PC12 cells without affecting progesterone action, identifying MAP2 as a specific neurosteroid receptor.\",\n      \"method\": \"Ligand binding assay, microtubule polymerization assay, siRNA knockdown of MAP2, neurite outgrowth measurement in PC12 cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the USA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function knockdown with specific phenotypic rescue specificity, binding assay\",\n      \"pmids\": [\"16537405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"DHEA specifically binds to the N-terminal region of MAP2c with an association constant of 2.7×10^7 M^-1 (molar ratio 1:1), as determined by isothermal titration calorimetry, and the binding site was mapped by partial tryptic digestion and mass spectrometry.\",\n      \"method\": \"Isothermal titration calorimetry, partial tryptic digestion, mass spectrometry, structural modeling\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro binding with ITC plus site mapping by proteolysis/MS\",\n      \"pmids\": [\"12775713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Sequence analysis of MAP2c deletion mutants in transfected non-neuronal cells showed that microtubule-binding strength increases with repeat number, that contiguous sequences flanking the repeats (especially the N-terminal proline-rich domain) are required for efficient binding, and that bundling and process outgrowth are directly correlated with binding strength.\",\n      \"method\": \"MAP2c deletion mutant transfection in non-neuronal cells, immunofluorescence-based binding and bundling assay, process outgrowth measurement\",\n      \"journal\": \"Journal of Cell Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic deletion mutagenesis series with quantitative functional readouts\",\n      \"pmids\": [\"7699010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"ApoE3, but not apoE4, binds MAP2c with high avidity detectable down to 10^-9 M MAP2c and 10^-8 M apoE3, demonstrating isoform-specific interaction between apolipoprotein E and MAP2c.\",\n      \"method\": \"In vitro protein binding assay comparing apoE2, apoE3, apoE4 isoforms with MAP2c\",\n      \"journal\": \"Neuroscience Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single pulldown-type binding assay, single lab\",\n      \"pmids\": [\"7891887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"MAP2c-bundled microtubules in transfected fibroblasts are extremely stable (less than 10% tubulin exchange within 1 hour by photoactivation), yet exogenously introduced tubulin rapidly incorporates at the distal ends of bundles, demonstrating that MAP2c stabilizes microtubule polymer while maintaining open plus ends for assembly.\",\n      \"method\": \"cDNA transfection, microinjection of biotin-labeled tubulin, photoactivation of caged fluorescein-labeled tubulin, immunofluorescence\",\n      \"journal\": \"The Journal of Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vivo dynamics with photoactivation plus microinjection\",\n      \"pmids\": [\"8421058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Juvenile MAP2c and mature MAP2 isoforms expressed in Sf9 insect cells produce distinct patterns of process outgrowth: MAP2c induces multiple short thin processes with closely and variably spaced microtubules, while mature MAP2 induces single thick processes with proximo-distal taper and decreasing microtubule number, showing that MAP2 isoforms differentially determine microtubule architecture and process morphology.\",\n      \"method\": \"Baculovirus expression in Sf9 cells, electron microscopy of process cross-sections, microtubule spacing measurement\",\n      \"journal\": \"Molecular Biology of the Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — heterologous expression with ultrastructural quantitative analysis\",\n      \"pmids\": [\"8868472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Deletion of the N-terminal PKA-binding domain (residues 1-158) of MAP2 in knock-in mice reduces MAP2 phosphorylation efficiency, alters hippocampal CA1 neuron morphology, and specifically impairs contextual (but not cued) fear memory, demonstrating that PKA anchoring to MAP2 is required for contextual memory formation.\",\n      \"method\": \"Homologous recombination knock-in mouse, immunohistochemistry, behavioral fear conditioning assay\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — precision genetic deletion with defined behavioral and biochemical phenotypes\",\n      \"pmids\": [\"12763072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"A MAP2 kinase co-purified from chicken embryonic brain (Mr=100,000) phosphorylates MAP2 at serine residues and completely reverses MAP2-mediated inhibition of kinesin/dynein-driven microtubule motility by releasing MAP2 from microtubules; other kinases (Cdc2, MAPK, NIMA) can phosphorylate MAP2 but do not change its affinity for microtubules.\",\n      \"method\": \"In vitro motility assay, co-purification of kinase with MAP2, in vitro phosphorylation with multiple kinases, comparison of affinity effects\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of motility with defined biochemical dissection of kinase specificity\",\n      \"pmids\": [\"7759496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Ser136 within a Ser-Pro motif at the N-terminus of MAP2b/c is phosphorylated in vivo by proline-directed kinases (MAP kinase, GSK-3, cdks) but not by PKA, PKC, or CaMKII; microinjected MAP2 isoforms become phosphorylated at Ser136 in multiple cell lines, and this phosphorylation is independent of MAP2-induced microtubule reorganization.\",\n      \"method\": \"Site-directed mutagenesis of recombinant MAP2c, epitope mapping with monoclonal antibody AP18, in vitro kinase assays, microinjection into cell lines\",\n      \"journal\": \"European Journal of Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis plus multiple in vitro kinase assays plus in vivo microinjection validation\",\n      \"pmids\": [\"7525290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"L1CAM directly binds MAP2c (but not MAP2a/b) via ELISA-confirmed direct binding between MAP2c and the intracellular domain of L1; L1 enhances MAP2a/b/c expression through the MAPK pathway, and combined L1 and MAP2 deficiency reduces neurite outgrowth in vitro.\",\n      \"method\": \"ELISA direct binding assay, co-immunoprecipitation, MAP2 mRNA/protein measurement in L1-deficient mice, MAPK pathway inhibitor treatment, neurite outgrowth assay\",\n      \"journal\": \"Molecular and Cellular Neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding assay plus co-IP plus genetic mouse model with defined pathway inhibition\",\n      \"pmids\": [\"22503709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NCAM2 forms a protein complex with MAP2 and 14-3-3γ/ζ; NCAM2 depletion destabilizes the microtubular network, reduces MAP2 signal, and causes severe dendritic architecture defects (shorter dendritic trees, dendrite retraction, numerous somatic neurites) and impaired neuronal polarization in hippocampal neurons and in vivo.\",\n      \"method\": \"Proteomic analysis, co-immunoprecipitation, shRNA knockdown in hippocampal neurons, in vivo cortical studies, immunofluorescence\",\n      \"journal\": \"Cerebral Cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — proteomics plus co-IP plus loss-of-function with defined phenotype in vitro and in vivo\",\n      \"pmids\": [\"32043120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MAP2, CaMKIIα, and β-actin mRNAs localize to dendrites in distinct ribonucleoprotein particles containing very few RNA molecules; the number of MAP2 molecules per particle is regulated by synaptic activity and Staufen 2.\",\n      \"method\": \"Single-molecule FISH, live imaging of fluorescently tagged mRNAs, Staufen 2 manipulation, synaptic stimulation\",\n      \"journal\": \"EMBO Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — single-molecule resolution imaging with functional manipulation of RNP composition\",\n      \"pmids\": [\"21869818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"MAP2 forms antiparallel dimers approximately 97 nm in length; chymotryptic fragments were mapped showing the C-terminal microtubule-binding domain generates a 36 kDa fragment, and the N-terminal AP18 epitope (phosphorylation-dependent) is at the opposite end of the rod-like molecule from the microtubule-binding repeats.\",\n      \"method\": \"Limited proteolysis, electron microscopy of negatively stained molecules, antibody labeling, electron microscopy\",\n      \"journal\": \"Journal of Structural Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural characterization by EM with antibody epitope mapping and proteolytic domain dissection\",\n      \"pmids\": [\"1373291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In vitro fluorescence microscopy and flexural rigidity measurements showed that the MAP2 microtubule-binding domain makes microtubules less stiff and more flexible than tau-bound microtubules; in SH-SY5Y cells, MAP2-expressing protrusions have more branches than tau-expressing protrusions, linking MAP2's effect on microtubule mechanical properties to neurite branching.\",\n      \"method\": \"In vitro fluorescence microscopy of microtubule morphology, hydrodynamic flow teardrop assay for flexural rigidity, EGFP-MAP2 expression in SH-SY5Y cells\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biophysical reconstitution with in-cell validation\",\n      \"pmids\": [\"37258650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"MAP2 is colocalized with actin in dendritic spines by immunogold electron microscopy, where MAP2 immunolabeling is primarily associated with actin filaments, demonstrating that MAP2 functions as an actin-associated protein in spine compartments independently of microtubules.\",\n      \"method\": \"Immunogold double-labeling electron microscopy of dendritic spines\",\n      \"journal\": \"Cell and Tissue Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — immunoEM colocalization in spines, single lab\",\n      \"pmids\": [\"2743390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"MAP2 binds to the Sau96.1 restriction fragment of mouse satellite DNA containing a poly(dA)4/poly(dT)4 sequence; DNase protection assay shows MAP2 specifically protects this dA/dT sequence from digestion.\",\n      \"method\": \"DNA-protein binding assay, DNase protection assay\",\n      \"journal\": \"The EMBO Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — in vitro DNA binding assay, functional significance uncertain, single method\",\n      \"pmids\": [\"10872313\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MAP2 is a neuron-specific, somatodendritically localized microtubule-associated protein whose carboxyl-terminal repeat domain binds microtubules (and actin) to stabilize, bundle, and stiffen them, promoting dendritic elongation and branching; its activity is bidirectionally regulated by phosphorylation (by PKA, cdc2/CDKs, MARK, GSK3β, and CaMKII) and dephosphorylation (by calcineurin downstream of NMDA receptors), which controls its affinity for microtubules versus the actin cytoskeleton; its N-terminal domain anchors PKA (RIIβ) in dendrites and directly binds L-type Ca²⁺ channels and neurosteroids (PREG, DHEA); its high-molecular-weight isoforms contain a dendritic mRNA targeting element in the 3' UTR enabling local synthesis, while its protein is targeted to dendrites via a signal within the coding sequence; collectively, MAP2 integrates cytoskeletal regulation with PKA signaling to control dendritic architecture, synaptic plasticity, and contextual memory.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEEP papers.\n\n**Classification notes:**\n- The main corpus (100 papers) is largely about canonical MAP2 (microtubule-associated protein 2, neuronal) — KEEP most\n- Paper [39] in main corpus: \"MAP-2 kinase\" = ERK/MAPK (an alias collision — \"MAP-2K\" here refers to the kinase that phosphorylates MAP2 as a substrate in T-cell signaling context, but actually describes CD3/CD4-mediated activation of what is now called ERK). This describes a kinase activity using MAP2 as a substrate readout, not MAP2 itself mechanistically. EXCLUDE (alias collision — MAP2K = MAPK kinase, not MAP2 protein function).\n- Paper [54] in main corpus: \"MAP2 kinases\" = MKK4/MKK7 (MAP2K = MAP kinase kinase) — alias collision. EXCLUDE.\n- Paper [13] in main corpus: \"MAP2 kinases\" = cdc2 and MAP kinase used as kinases acting on tau — mentions MAP2 kinase as an enzyme, not MAP2 protein. Partially relevant as it shows cdc2 phosphorylates tau but uses \"MAP2 kinase\" as the enzyme name. EXCLUDE (alias collision).\n- Additional gene2pubmed papers: All appear to be about MASP-2 (complement pathway) or other genes — EXCLUDE all 30 additional papers.\n- Paper [94]: about miR-484/MAP2/c-Myc in glioma — MAP2 here is the canonical protein being targeted by miR-484. KEEP (mechanistic finding about MAP2 in glioma context).\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"The carboxyl-terminal domain of MAP2 containing three imperfect 18-amino acid repeats constitutes the microtubule binding site. A subcloned fragment spanning the first two repeats co-purified with microtubules through successive polymerization/depolymerization cycles, whereas the amino-terminal region failed to co-purify.\",\n      \"method\": \"In vitro translation of subcloned MAP2 fragments followed by microtubule co-purification (cycles of polymerization/depolymerization); complete cDNA sequencing\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with domain deletion mapping, foundational paper with 463 citations\",\n      \"pmids\": [\"3142041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"MAP2 mRNA is selectively localized in dendrites of developing brain neurons, whereas tubulin mRNA is restricted to neuronal cell bodies, demonstrating that dendritic targeting of MAP2 protein can occur via local dendritic mRNA translation.\",\n      \"method\": \"In situ hybridization with specific cDNA probes on developing brain tissue\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional implication, replicated across labs, 499 citations\",\n      \"pmids\": [\"3200318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1984,\n      \"finding\": \"MAP2 is selectively localized to neuronal dendrites and dendritic spines (including postsynaptic densities), but is absent from axons, as demonstrated with monoclonal antibodies. MAP2 association with postsynaptic densities and spines suggests functions independent of microtubule binding.\",\n      \"method\": \"Immunocytochemistry with monoclonal hybridoma antibodies on brain tissue sections; immunoelectron microscopy\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct subcellular localization by immunoEM, replicated across multiple antibody clones, 342 citations\",\n      \"pmids\": [\"6699682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"MAP2 forms crossbridges between microtubules and neurofilaments in neuronal dendrites in vivo. Reconstitution experiments showed MAP2 binds neurofilament L protein in vitro and crosslinks neurofilaments with microtubules.\",\n      \"method\": \"Quick-freeze deep-etch immunoelectron microscopy with anti-MAP2 antibody and ferritin-labeled secondary; in vitro reconstitution with isolated neurofilament L protein and MAP2\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution combined with immunoEM in vivo validation, 172 citations\",\n      \"pmids\": [\"3045269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"MAP2 expression in non-neuronal fibroblasts via cDNA transfection stabilizes microtubules against depolymerizing reagents and promotes accumulation of acetylated alpha-tubulin, demonstrating that MAP2 directly confers microtubule stability in living cells.\",\n      \"method\": \"cDNA transfection of MAP2/MAP2c into fibroblasts; treatment with microtubule depolymerizing reagents; immunofluorescence for acetylated tubulin\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean gain-of-function in non-neuronal cells with orthogonal readouts (drug resistance + post-translational modification), 292 citations\",\n      \"pmids\": [\"1487506\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"MAP2 is required for dendritic elongation and serves as an anchoring protein for the regulatory subunit II of cAMP-dependent protein kinase (PKA) in dendrites. MAP2-knockout mice show reduced microtubule density and dendritic length, reduced PKA subunits in dendrites, and impaired CREB phosphorylation after forskolin stimulation.\",\n      \"method\": \"MAP2-deficient (knockout) mice; microtubule density measurement; PKA subunit immunostaining and Western blot; phospho-CREB assay after forskolin stimulation in cultured neurons\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple orthogonal phenotypic readouts (morphology, biochemistry, signaling), 282 citations\",\n      \"pmids\": [\"12163474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"NMDA receptor activation induces rapid dephosphorylation (~70% decrease) of MAP2 in hippocampal slices without changing total MAP2 levels. The effect is blocked by NMDA antagonists and is distinct from non-NMDA receptor activation, suggesting calcium/calmodulin-dependent phosphatase (calcineurin) mediates NMDA-induced MAP2 dephosphorylation.\",\n      \"method\": \"32P-orthophosphate labeling of hippocampal slices; pharmacological dissection with competitive and non-competitive NMDA antagonists; SDS-PAGE phosphoprotein analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean pharmacological dissection with radiolabeled phosphate, replicated across brain regions, 202 citations\",\n      \"pmids\": [\"2169265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1984,\n      \"finding\": \"Pre-phosphorylation of MAP2 by a co-purifying cAMP-independent protein kinase decreases MAP2 affinity for taxol-stabilized microtubules and increases the dissociation rate of microtubule polymerization in a phosphorylation level-dependent manner, demonstrating that MAP2 phosphorylation regulates microtubule binding and length.\",\n      \"method\": \"In vitro kinase phosphorylation of MAP2; microtubule binding assays with taxol-stabilized microtubules; polymerization kinetics measurements\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro reconstitution with dose-response phosphorylation, 118 citations\",\n      \"pmids\": [\"6146522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Glutamate produces a biphasic regulation of MAP2 phosphorylation: rapid transient increase via metabotropic receptors (attenuated by CaMKII and PKC inhibitors), followed by persistent dephosphorylation via NMDA receptors and calcineurin (calcium/calmodulin-dependent phosphatase 2B). MAP2 phosphorylation state determines its interaction with microtubules and actin.\",\n      \"method\": \"32P-labeling of neurons; pharmacological dissection with glutamate receptor agonists/antagonists, CaMKII inhibitors, PKC inhibitors, calcineurin inhibitors; immunoprecipitation\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional pharmacological dissection with radiolabeled phosphate, multiple kinase/phosphatase pathway assignments, 117 citations\",\n      \"pmids\": [\"8789950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"The repeated tubulin-binding sequence motif in both MAP2 and tau also mediates actin binding. A synthetic peptide corresponding to one of the repeated tubulin-binding sites binds G-actin by affinity chromatography and co-sediments with F-actin.\",\n      \"method\": \"Affinity chromatography of G-actin on synthetic peptide column; co-sedimentation of F-actin with peptide; immunoelectron microscopy co-localization\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution with multiple orthogonal methods, 125 citations\",\n      \"pmids\": [\"2115775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MAP2B (a high molecular weight MAP2 isoform) directly binds the alpha1 subunit of class C L-type Ca2+ channels and serves as an A-kinase anchor protein (AKAP) that recruits PKA to postsynaptic sites containing these channels. MAP2B association with channels is microtubule-independent.\",\n      \"method\": \"Immunoprecipitation from rat brain extracts; direct protein overlay binding assay with 32P-labeled RIIβ; immunoblotting; in vitro binding assay with purified channel alpha1 subunit; nocodazole treatment to rule out microtubule dependence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus in vitro direct binding assay, multiple orthogonal controls, 121 citations\",\n      \"pmids\": [\"10514522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MARK kinases phosphorylate MAP2c (and MAP4) on their microtubule-binding domain in transfected CHO cells, causing detachment of MAP2 from microtubules, increased microtubule dynamic instability, and eventual microtubule disruption and vimentin network breakdown.\",\n      \"method\": \"Inducible expression of MARK1/MARK2 in CHO cells; immunofluorescence; microtubule stability assays; phosphorylation-state analysis\",\n      \"journal\": \"Cell motility and the cytoskeleton\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined kinase expressed in cells with clear cytoskeletal phenotype and mechanistic follow-up, 127 citations\",\n      \"pmids\": [\"10542369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"High molecular weight MAP2 isoforms (MAP2a/b) contain a large N-terminal sidearm domain responsible for cross-linking dendritic microtubules and a dendritic targeting signal. The embryonic MAP2c isoform, generated by alternative splicing lacking 1,342 amino acids of the sidearm, has no dendritic mRNA targeting, indicating the targeting signal is specific to the high-molecular-weight forms.\",\n      \"method\": \"cDNA cloning and sequencing of MAP2 isoforms; in situ hybridization for MAP2c mRNA; electron microscopy of reconstituted microtubules\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — alternative splicing characterized with structural and localization data, 116 citations\",\n      \"pmids\": [\"2770869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"MAP2c-stabilized microtubule bundles in transfected non-neuronal cells support process outgrowth when actin is depolymerized by cytochalasin B. This effect is specific to MAP2c and does not occur with taxol-stabilized microtubules, demonstrating that MAP2c confers stability, bundling, and stiffness to microtubules—properties required for neurite-like process formation.\",\n      \"method\": \"MAP2c cDNA transfection into non-neuronal cells; cytochalasin B treatment; video time-lapse microscopy; comparison with taxol-treated controls\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean gain-of-function with specific pharmacological perturbation and live imaging, 110 citations\",\n      \"pmids\": [\"8392463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"cAMP-dependent protein kinase (PKA) activity disrupts the MAP2c-microtubule interaction in HeLa cells by phosphorylating serines within KXGS motifs (one per tubulin-binding repeat). Double or triple KXGS-to-glutamate mutations promote MAP2c redistribution to peripheral actin-enriched membrane ruffles, demonstrating phosphorylation-dependent switching between microtubule and actin cytoskeletal associations.\",\n      \"method\": \"PKA activation in HeLa cells expressing MAP2c; site-directed mutagenesis of KXGS motifs to glutamate (phosphomimetic); immunofluorescence and detergent extraction to assess cytoskeletal association; biochemical fractionation\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis combined with cell-based and biochemical assays, 106 citations\",\n      \"pmids\": [\"11029056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A 640-nucleotide cis-acting dendritic targeting element (DTE) within the 3' UTR of MAP2 mRNA is both necessary and sufficient for dendritic localization of chimeric mRNAs in hippocampal and sympathetic neurons. The 5' UTR and coding region do not confer dendritic targeting.\",\n      \"method\": \"Chimeric mRNA reporter constructs transfected into hippocampal neurons and microinjected into sympathetic neurons; in situ hybridization to detect RNA distribution\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — necessity and sufficiency tested in two distinct neuronal cell types, 143 citations\",\n      \"pmids\": [\"10516301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Phosphorylation of MAP2 by cdc2 kinase (7-10 mol phosphate/mol MAP2, >60% in microtubule-binding region) abolishes both microtubule-stabilizing and microtubule-nucleating activities. PKA phosphorylation (15 mol/mol, ~70% in projection region) reduces only microtubule-nucleating activity, not stabilizing activity. Direct observation of individual microtubules by dark-field microscopy revealed distinct mechanistic consequences.\",\n      \"method\": \"In vitro phosphorylation by purified PKA and cdc2 kinase; dark-field microscopy of individual microtubules; quantification of polymerization phases and nucleation\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with distinct kinases and direct single-microtubule visualization, 72 citations\",\n      \"pmids\": [\"9376363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GSK3β phosphorylates MAP2c at Thr1620/Thr1623 (recognized by antibody 305) in co-transfected COS-1 cells, preventing microtubule bundle formation. Lithium chloride (GSK3 inhibitor) reverses this effect. Highly phosphorylated MAP2c species are enriched in cytoskeleton-unbound fractions.\",\n      \"method\": \"Co-transfection of MAP2c with wild-type or mutant GSK3β in COS-1 cells; lithium chloride inhibitor treatment; immunofluorescence for microtubule bundles; cytoskeletal fractionation; site-specific antibody staining\",\n      \"journal\": \"European journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined kinase co-expression with pharmacological rescue, 77 citations\",\n      \"pmids\": [\"10826493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"MAP2c reorganizes cellular microtubules into stable bundles independent of the microtubule-organizing center (MTOC) when expressed in non-neuronal cells. The bundles are stiff and long, with curvature only from cortical cytoskeleton constraint, demonstrating MAP2c imparts both stability and stiffness to microtubules.\",\n      \"method\": \"cDNA transfection of MAP2c into non-neuronal cell lines; immunofluorescence; comparison with taxol and DMSO treatment\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function in non-neuronal cells with mechanistic comparisons, 102 citations\",\n      \"pmids\": [\"1338311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Biotin-labeled MAP2 microinjected into spinal cord neurons enters both axons and dendrites initially, but is selectively lost from axons over 3+ days. Immunoelectron microscopy shows axonal MAP2 is largely not cytoskeleton-associated, whereas dendritic MAP2 is cytoskeleton-bound, indicating differential cytoskeletal affinity (not sorting at cell body) underlies MAP2 compartmentalization.\",\n      \"method\": \"Microinjection of biotin-labeled MAP2 into cultured spinal cord neurons; immunoelectron microscopy; detergent extraction prior to immunocytochemistry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct protein tracking by microinjection with ultrastructural analysis, 61 citations\",\n      \"pmids\": [\"2657741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"MAP2C stabilizes microtubule bundles such that <10% of tubulin is exchanged within 1 hour (assessed by photoactivation of caged fluorescein-tubulin), yet exogenously introduced tubulin rapidly incorporates at distal bundle ends. This reveals that MAP2c-bundled microtubules are extremely stable internally while remaining capable of assembly at ends.\",\n      \"method\": \"Photoactivation of caged fluorescein-labeled tubulin in MAP2c-transfected fibroblasts; microinjection of biotin-labeled tubulin; immunofluorescence with anti-biotin\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo dynamic measurement by photoactivation, 61 citations\",\n      \"pmids\": [\"8421058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The neurosteroid pregnenolone (PREG) and its analog MePREG bind directly to MAP2 and stimulate microtubule polymerization. RNAi knockdown of MAP2 abolishes the stimulatory effects of PREG/MePREG on neurite extension in NGF-treated PC12 cells but does not affect progesterone action, demonstrating MAP2 is the specific receptor for these neurosteroids.\",\n      \"method\": \"Neurite outgrowth assays in PC12 cells; RNA interference knockdown of MAP2; nocodazole protection assay; MAP2 immunostaining quantification\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with specific neurosteroid/receptor assignment, single lab\",\n      \"pmids\": [\"16537405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"DHEA binds specifically to the N-terminal region of MAP2c with an association constant of 2.7×10^7 M^-1 at 1:1 molar ratio, as measured by isothermal titration calorimetry. Tryptic digestion and mass spectrometry localized the binding site to the N-terminus. Structural modeling based on sequence homology with 17β-hydroxysteroid dehydrogenase 1 identified specific hydrogen bonds orienting DHEA in the binding pocket.\",\n      \"method\": \"Isothermal titration calorimetry; partial tryptic digestion; mass spectrometry; computational structural modeling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — quantitative binding measurement with domain mapping, single lab, 47 citations\",\n      \"pmids\": [\"12775713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"ApoE3 but not ApoE4 binds MAP2c with high avidity (detectable down to 10^-9 M MAP2c and 10^-8 M apoE3), paralleling its differential binding to tau. This isoform-specific interaction suggests apoE genotype may affect intracellular microtubule maintenance via MAP2c binding.\",\n      \"method\": \"Direct binding assay between apoE isoforms and MAP2c; concentration-dependent binding analysis\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single binding assay, single lab, but clear isoform specificity demonstrated\",\n      \"pmids\": [\"7891887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"MAP2 microtubule binding requires the repeat domain plus contiguous sequences on either side (particularly the proline-rich domain N-terminal to the repeats). Deletion mutant analysis shows binding strength increases with number of repeats present, and microtubule bundling and process outgrowth capacity correlate with binding strength.\",\n      \"method\": \"Series of deletion mutants of MAP2c transfected into non-neuronal cells; immunofluorescence for microtubule association and bundle formation; process outgrowth assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic deletion mutagenesis with multiple functional readouts, 64 citations\",\n      \"pmids\": [\"7699010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"High-molecular-weight MAP2 binds phosphatidylinositol with high affinity (Kd ~51 nM) compared to MAP2c, tau, and recombinant human tau (~1.4-2.4 μM). The high affinity is due to two interactions: a low-affinity site in the C-terminal domain shared with MAP2c/tau, and a high-affinity site (Kd ~221 nM) in the MAP2-specific projection domain eliminated by alternative splicing in MAP2c.\",\n      \"method\": \"Binding to phosphatidylinositol and phosphatidylcholine vesicles; thrombin digestion of MAP2c; affinity measurements\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro binding with domain-mapping using proteolytic fragments, single lab\",\n      \"pmids\": [\"8025110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Juvenile MAP2c and mature (full-length) MAP2 induce distinct patterns of process outgrowth in Sf9 insect cells: MAP2c induces multiple short thin processes with closely-spaced microtubules, while mature MAP2 induces single thick processes with proximo-distal taper and decreasing microtubule number, establishing MAP2 isoforms as architectural determinants of process morphology.\",\n      \"method\": \"Baculovirus expression in Sf9 cells; electron microscopy of processes; measurement of microtubule spacing and number along processes\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — comparative isoform expression with ultrastructural analysis, single lab\",\n      \"pmids\": [\"8868472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"MAP2 forms antiparallel dimers as shown by electron microscopy and antibody labeling. Intact MAP2 forms rod-like particles of ~97 nm. Major chymotryptic fragments map to a 36 kDa microtubule-binding fragment (~49 nm rods) and the AP18 antibody epitope maps to the first 151 residues; AP18 binding is phosphorylation-dependent.\",\n      \"method\": \"Limited proteolysis; electron microscopy; antibody epitope mapping; phosphorylation-dependent antibody binding assay\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — structural characterization with biochemical validation, single lab\",\n      \"pmids\": [\"1373291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"MAP2 phosphorylation at Ser136 (a Ser-Pro motif) in vivo and in vitro is catalyzed by proline-directed kinases (MAP kinase, GSK-3, cdk family members) but not by PKA, PKC, or CaMKII. This site is endogenously phosphorylated in brain MAP2. Microinjection of MAP2 into cells induces microtubule reorganization regardless of Ser136 phosphorylation state.\",\n      \"method\": \"Site-directed mutagenesis of Ser136; in vitro phosphorylation with multiple purified kinases; monoclonal antibody AP18 for phospho-specific detection; microinjection into cell lines\",\n      \"journal\": \"European journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — site-directed mutagenesis combined with in vitro kinase specificity panel and in vivo validation, 57 citations\",\n      \"pmids\": [\"7525290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"MAP2 binds to a poly(dA)4/poly(dT)4 sequence present in mouse satellite DNA (Sau96.1 restriction fragment). DNase protection assay showed MAP2 specifically protects this dA/dT sequence from digestion.\",\n      \"method\": \"Affinity binding of MAP2 to satellite DNA restriction fragments; DNase I protection assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single biochemical assay, functional significance unclear, single lab\",\n      \"pmids\": [\"10872313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MAP2 mRNA localizes to dendrites in distinct ribonucleoprotein particles (RNPs) containing very few RNA molecules per particle. The number of MAP2 mRNA molecules per RNP is regulated by synaptic activity and by Staufen 2, demonstrating that RNP composition controlling MAP2 mRNA transport is dynamically controlled.\",\n      \"method\": \"Single-molecule fluorescence in situ hybridization; Staufen 2 manipulation; synaptic activity modulation; quantitative RNP analysis\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct quantitative single-molecule RNA visualization with functional manipulation, single lab\",\n      \"pmids\": [\"21869818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"L1CAM (L1 cell adhesion molecule) binds directly to MAP2c via ELISA, and promotes MAP2a/b/c expression through the MAPK pathway. L1-deficient mice show reduced MAP2c mRNA and protein. Co-immunoprecipitation shows MAP2a/b associates with L1 via intermediate partners. Combined L1 and MAP2 deficiency reduces neurite outgrowth.\",\n      \"method\": \"ELISA direct binding assay (MAP2c to intracellular domain of L1); co-immunoprecipitation; L1-deficient mouse brain analysis; MAPK pathway inhibition; neurite outgrowth assays\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct binding plus genetic mouse model, MAPK pathway pharmacological inhibition, single lab\",\n      \"pmids\": [\"22503709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"A MAP2-associated kinase (embryonic MAP2 kinase, Mr=100,000) co-purified with chicken embryonic MAP2 reverses MAP2-mediated inhibition of microtubule-based motor (kinesin/dynein) motility by phosphorylating MAP2 at serine residues and releasing it from microtubules. This kinase is cAMP-independent and distinct from cdc2, MAPK, bovine MAP2 kinase, and NIMA kinase.\",\n      \"method\": \"In vitro microtubule gliding motility assay; kinase co-purification; phosphorylation analysis; inhibitor profiling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro functional reconstitution of motility rescue, single lab\",\n      \"pmids\": [\"7759496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Deletion of the N-terminal 158 amino acids of MAP2 (which contains the PKA-RIIβ binding site) in mice results in decreased MAP2 phosphorylation efficiency, major changes in hippocampal neuron morphology, and selective impairment of contextual (but not auditory cue) fear memory, demonstrating that PKA anchoring to MAP2 is essential for contextual memory formation.\",\n      \"method\": \"Homologous recombination gene targeting (N-terminal deletion); immunohistochemistry; behavioral fear conditioning tests; biochemical phosphorylation analysis\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — precise genetic deletion of functional domain with behavioral, morphological and biochemical readouts, 51 citations\",\n      \"pmids\": [\"12763072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NMR and cryo-EM analysis reveals that MAP2c and tau40 are intrinsically disordered but contain transient local structural motifs (molecular recognition elements) in free solution. These short sequence motifs exhibiting transient structure correspond to functional interaction sites, and their interactions are regulated by phosphorylation. MAP2c and tau40 adopt defined conformations when bound to microtubules and filamentous actin.\",\n      \"method\": \"Nuclear magnetic resonance (NMR) conformational analysis; cryo-electron microscopy; comparison of free vs. complex-bound conformations; phosphorylation state analysis\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — NMR structural analysis, but primarily comparative/descriptive rather than mechanistic functional validation\",\n      \"pmids\": [\"30884818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MAP2 microtubule-binding domain fragments make microtubules more flexible (less straight) compared to tau-bound microtubules, as measured by teardrop pattern analysis in hydrodynamic flow. In SH-SY5Y cells, processes expressing MAP2 show more branching than tau-expressing processes. MAP2 differs from tau in imparting lower flexural rigidity to microtubules.\",\n      \"method\": \"Fluorescence microscopy of microtubules in hydrodynamic flow; teardrop pattern flexural rigidity analysis; transfection of MAP2/tau/MAP4 in SH-SY5Y cells; electron microscopy of processes\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — quantitative biophysical measurement combined with cell-based validation, single lab\",\n      \"pmids\": [\"37258650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NCAM2 forms a protein complex with MAP2 and 14-3-3γ/ζ in neurons. NCAM2 depletion leads to destabilization of the microtubular network and reduced MAP2 signal, severe dendritic architecture defects, and impaired neuronal polarization both in vitro and in vivo.\",\n      \"method\": \"Proteomic analysis; co-immunoprecipitation; NCAM2 shRNA knockdown in hippocampal neurons; in utero electroporation for in vivo studies; immunofluorescence\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — proteomic interaction combined with loss-of-function in vitro and in vivo, but MAP2 role is inferred rather than directly tested\",\n      \"pmids\": [\"32043120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TTLL7, a beta-tubulin polyglutamylase, is required for growth of MAP2-positive neurites. TTLL7 accumulates in the MAP2-enriched somatodendritic compartment, and RNAi knockdown of TTLL7 represses NGF-stimulated MAP2-positive neurite growth in PC12 cells while reducing polyglutamylated beta-tubulin.\",\n      \"method\": \"In vitro polyglutamylation assay with recombinant TTLL7; siRNA knockdown in PC12 and superior cervical ganglion neurons; immunofluorescence; Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro enzymatic assay combined with siRNA loss-of-function in neurons with specific neurite readout, 131 citations\",\n      \"pmids\": [\"16901895\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MAP2 is a neuron-specific, dendritically localized microtubule-associated protein that promotes microtubule polymerization, nucleation, stabilization, and bundling through a C-terminal repeat-containing microtubule-binding domain; its affinity for microtubules is bidirectionally regulated by phosphorylation (PKA and cdc2 at KXGS and Ser-Pro motifs reduce binding, while calcineurin-mediated dephosphorylation via NMDA receptor activation promotes it), and in the phosphorylated state MAP2 redistributes to the actin cytoskeleton; MAP2 also functions as an A-kinase anchoring protein (AKAP) that recruits PKA-RIIβ to dendrites (required for proper cAMP/CREB signaling and contextual memory), directly binds the alpha1 subunit of L-type Ca2+ channels, serves as a receptor for neurosteroids (PREG, DHEA) at its N-terminus, cross-links microtubules to neurofilaments, and its mRNA is targeted to dendrites via a 640-nt cis-acting element in its 3' UTR.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MAP2 is a neuron-specific microtubule-associated protein that organizes the dendritic cytoskeleton and integrates kinase signaling to control dendritic morphology, synaptic plasticity, and contextual memory. Its C-terminal repeat domain binds and stabilizes microtubules, promotes bundling, and also binds actin filaments; the resulting stabilized microtubule bundles generate compressive forces that drive process outgrowth, while MAP2 confers lower flexural rigidity than tau, favoring dendritic branching [PMID:3142041, PMID:1338311, PMID:8392463, PMID:37258650]. Phosphorylation by multiple kinases (PKA, cdc2, MARK, GSK3β, CaMKII) at KXGS and other motifs within the microtubule-binding domain detaches MAP2 from microtubules and can redirect it to actin-rich structures, while NMDA receptor-activated calcineurin dephosphorylates MAP2 to restore microtubule association, establishing bidirectional glutamatergic control of dendritic cytoskeletal dynamics [PMID:6146522, PMID:10542369, PMID:10514522, PMID:8789950, PMID:2169265]. The N-terminal projection domain anchors PKA regulatory subunit RIIβ and L-type Ca²⁺ channels at postsynaptic sites, and genetic disruption of this PKA-anchoring function impairs hippocampal CREB phosphorylation and contextual fear memory, while MAP2 mRNA is targeted to dendrites via a 3′ UTR cis-element for local synthesis [PMID:12163474, PMID:12763072, PMID:10516301].\",\n  \"teleology\": [\n    {\n      \"year\": 1983,\n      \"claim\": \"Establishing that MAP2 colocalizes with actin filaments in dendritic spines, independent of microtubules, raised the question of whether MAP2 functions beyond microtubule binding.\",\n      \"evidence\": \"Immunogold double-labeling electron microscopy of dendritic spines\",\n      \"pmids\": [\"2743390\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab, no biochemical confirmation of direct actin binding at this stage\", \"Functional consequence of spine localization unknown\"]\n    },\n    {\n      \"year\": 1984,\n      \"claim\": \"Two foundational questions were answered simultaneously: MAP2 is compartmentalized exclusively to somatodendritic microtubules and postsynaptic densities, and phosphorylation directly reduces its microtubule affinity and promotes depolymerization, establishing phosphorylation-dependent regulation of MAP2-microtubule interaction.\",\n      \"evidence\": \"Immunocytochemistry/immunoEM with monoclonal antibodies for localization; in vitro phosphorylation with kinetic microtubule binding/assembly assays\",\n      \"pmids\": [\"6699682\", \"6146522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the cAMP-independent kinase unknown\", \"Mechanism of somatodendritic restriction unexplained\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"The microtubule-binding site was mapped to C-terminal 18-amino-acid repeats, MAP2 mRNA was shown to localize to dendrites (enabling local synthesis), and MAP2 was found to crossbridge microtubules to neurofilaments, collectively defining its molecular architecture and dendritic cytoskeletal organizing roles.\",\n      \"evidence\": \"In vitro translation/co-purification domain mapping; in situ hybridization of mRNA in developing brain; quick-freeze deep-etch immunoEM plus in vitro reconstitution\",\n      \"pmids\": [\"3142041\", \"3200318\", \"3045269\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cis-elements for dendritic mRNA targeting not yet identified\", \"Contribution of individual repeats to binding strength unknown\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Differential cytoskeletal association—not a sorting mechanism—was shown to underlie MAP2 somatodendritic compartmentalization: axonal MAP2 is not cytoskeleton-bound and turns over rapidly, while dendritic MAP2 is stably associated with the cytoskeleton.\",\n      \"evidence\": \"Microinjection of biotin-labeled MAP2 into cultured spinal cord neurons with detergent extraction and immunoEM\",\n      \"pmids\": [\"2657741\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What determines differential cytoskeletal association between compartments is unknown\", \"Role of phosphorylation in compartment-specific binding not tested\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Alternative splicing was shown to generate MAP2c (lacking the 1,342-aa projection domain), which lacks dendritic mRNA targeting and microtubule crosslinking capacity, explaining developmental isoform switching and its functional consequences.\",\n      \"evidence\": \"cDNA cloning and splicing analysis plus in situ hybridization\",\n      \"pmids\": [\"2770869\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulatory mechanism of splice switching during development unknown\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"The tubulin-binding repeat was shown to also bind actin, providing a molecular basis for MAP2's dual cytoskeletal association, and NMDA receptor activation was found to trigger rapid MAP2 dephosphorylation via calcineurin, linking glutamatergic signaling to MAP2 regulation.\",\n      \"evidence\": \"Affinity chromatography and co-sedimentation with synthetic repeat peptide for actin binding; ³²P-labeling of hippocampal slices with NMDA pharmacology for dephosphorylation\",\n      \"pmids\": [\"2115775\", \"2169265\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether actin and tubulin binding are mutually exclusive or simultaneous not resolved\", \"Phosphatase identity (calcineurin) was inferred pharmacologically, not genetically confirmed\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Gain-of-function expression of MAP2c in non-neuronal cells demonstrated that MAP2 stabilizes microtubules, induces bundling, and confers resistance to depolymerizing agents, while structural EM revealed MAP2 forms antiparallel dimers ~97 nm long.\",\n      \"evidence\": \"cDNA transfection in fibroblasts with depolymerization resistance assay and anti-acetylated tubulin staining; limited proteolysis and negative-stain EM\",\n      \"pmids\": [\"1338311\", \"1487506\", \"1373291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dimerization interface not mapped at atomic resolution\", \"Whether dimerization is required for bundling not tested\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"MAP2c-stabilized microtubule bundles were shown to drive process outgrowth when cortical actin tension is relieved, and photoactivation experiments revealed MAP2c suppresses tubulin exchange along microtubule shafts while keeping plus ends open for assembly.\",\n      \"evidence\": \"MAP2c transfection plus cytochalasin B with video microscopy; photoactivation of caged fluorescein-tubulin in transfected fibroblasts\",\n      \"pmids\": [\"8392463\", \"8421058\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MAP2 selectively stabilizes lattice while permitting plus-end dynamics is mechanistically unexplained\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Systematic deletion mutagenesis showed microtubule-binding strength increases with repeat number and requires flanking proline-rich sequences, MAP2 binds phosphatidylinositol with high affinity through isoform-specific domains, and proline-directed kinases phosphorylate Ser136 independently of microtubule reorganization.\",\n      \"evidence\": \"Deletion mutant transfection series; lipid vesicle binding with Kd measurements; site-directed mutagenesis with in vitro kinase assays\",\n      \"pmids\": [\"7699010\", \"8025110\", \"7525290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of lipid binding for dendritic membrane association not tested in neurons\", \"Ser136 phosphorylation function remains obscure\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"A co-purified MAP2 kinase was shown to release MAP2 from microtubules and reverse MAP2-mediated inhibition of kinesin/dynein-driven motility, while other kinases (Cdc2, MAPK) phosphorylate MAP2 without altering microtubule affinity, demonstrating kinase-specific functional outcomes.\",\n      \"evidence\": \"In vitro motility assay with co-purified kinase versus Cdc2/MAPK/NIMA\",\n      \"pmids\": [\"7759496\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the co-purified 100 kDa kinase not determined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Glutamate was found to exert bidirectional control of MAP2 phosphorylation—rapid increase via metabotropic receptors/CaMKII/PKC followed by persistent dephosphorylation via NMDA/calcineurin—and MAP2 versus MAP2c isoforms were shown to produce morphologically distinct process architectures.\",\n      \"evidence\": \"Pharmacological dissection with kinase/phosphatase inhibitors in hippocampal neurons; baculovirus expression in Sf9 cells with EM\",\n      \"pmids\": [\"8789950\", \"8868472\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Bidirectional phosphorylation not mapped to specific sites in neurons\", \"Whether isoform-specific morphology reflects projection domain length alone is unclear\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"cdc2 kinase was shown to inhibit both microtubule-stabilizing and nucleating activities of MAP2, while PKA affects only nucleation, establishing that different kinases regulate distinct MAP2 functions.\",\n      \"evidence\": \"In vitro phosphorylation with dark-field single-microtubule visualization\",\n      \"pmids\": [\"9376363\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation sites responsible for each functional effect not individually mapped\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Three key mechanistic advances: MARK kinases phosphorylate KXGS motifs to detach MAP2 from microtubules; a 640-nt 3′ UTR element is necessary and sufficient for dendritic mRNA targeting; and MAP2B directly binds L-type Ca²⁺ channel α1 subunits and anchors PKA at postsynaptic sites.\",\n      \"evidence\": \"MARK co-transfection in CHO cells; chimeric mRNA transfection/microinjection in neurons; co-IP plus direct binding assay from rat brain\",\n      \"pmids\": [\"10542369\", \"10516301\", \"10514522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MARK phosphorylation of MAP2 occurs in neuronal dendrites in vivo not shown\", \"Trans-acting factors for 3′ UTR-mediated targeting not identified\", \"Stoichiometry of MAP2B-channel-PKA complex unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"PKA phosphorylation of KXGS motifs was shown to redirect MAP2c from microtubules to actin-rich membrane ruffles, and GSK3β phosphorylation at Thr1620/1623 prevents microtubule bundling, demonstrating that phosphorylation acts as a cytoskeletal switch.\",\n      \"evidence\": \"KXGS→KEGS mutagenesis in HeLa cells with PKA activation; GSK3β co-transfection in COS-1 cells with lithium rescue\",\n      \"pmids\": [\"10514522\", \"10826493\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKA-driven microtubule-to-actin switching occurs in dendrites not demonstrated\", \"Interplay between GSK3β and MARK phosphorylation not examined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"MAP2 knockout mice revealed that MAP2 is required for normal microtubule density, dendritic length, dendritic anchoring of PKA subunits, and forskolin-stimulated CREB phosphorylation, establishing MAP2 as an essential scaffold linking cytoskeletal organization to cAMP/PKA signaling in dendrites.\",\n      \"evidence\": \"MAP2 knockout mice with immunofluorescence, Western blot, PKA subunit localization, and CREB phosphorylation assay\",\n      \"pmids\": [\"12163474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Behavioral phenotype of full knockout not reported in this study\", \"Compensatory upregulation of other MAPs not fully assessed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Deletion of the MAP2 PKA-binding domain in knock-in mice specifically impaired contextual but not cued fear memory, directly demonstrating that MAP2's AKAP function is required for hippocampus-dependent memory, and DHEA was found to bind the MAP2c N-terminus with high affinity.\",\n      \"evidence\": \"Knock-in mice with behavioral fear conditioning; isothermal titration calorimetry with tryptic mapping for DHEA binding\",\n      \"pmids\": [\"12763072\", \"12775713\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling events through which PKA anchoring supports memory consolidation not elucidated\", \"Physiological role of DHEA-MAP2 binding in neurons not established\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"MAP2 was identified as a direct receptor for neurosteroids pregnenolone and DHEA: binding stimulates microtubule polymerization and neurite outgrowth, and MAP2 knockdown specifically blocks neurosteroid-stimulated (but not progesterone-stimulated) outgrowth.\",\n      \"evidence\": \"Ligand binding assay, microtubule polymerization assay, siRNA knockdown in NGF-pretreated PC12 cells\",\n      \"pmids\": [\"16537405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether neurosteroid-MAP2 signaling operates in mature neurons in vivo unknown\", \"Structural basis of neurosteroid selectivity not resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Single-molecule FISH revealed that MAP2 mRNA travels in dendrites in distinct ribonucleoprotein particles containing very few RNA molecules, with particle composition regulated by synaptic activity and Staufen 2.\",\n      \"evidence\": \"Single-molecule FISH and live imaging with Staufen 2 manipulation and synaptic stimulation\",\n      \"pmids\": [\"21869818\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full protein composition of MAP2 mRNA transport granules unknown\", \"How Staufen 2 regulates MAP2 mRNA copy number per granule mechanistically unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"L1CAM was shown to directly bind MAP2c (but not MAP2a/b) and to enhance MAP2 expression through the MAPK pathway, revealing a cell adhesion molecule–cytoskeletal feedback loop for neurite outgrowth.\",\n      \"evidence\": \"ELISA direct binding, co-IP, L1-deficient mice, MAPK inhibitor treatment, neurite outgrowth assay\",\n      \"pmids\": [\"22503709\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why L1 binds MAP2c but not MAP2a/b structurally unexplained\", \"In vivo relevance of L1-MAP2 interaction for dendritic development not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"NCAM2 was found to form a complex with MAP2 and 14-3-3 proteins; NCAM2 loss destabilizes the microtubule network, reduces MAP2 levels, and causes severe dendritic architecture defects and impaired neuronal polarization.\",\n      \"evidence\": \"Proteomics, co-IP, shRNA knockdown in hippocampal neurons and in vivo cortical studies\",\n      \"pmids\": [\"32043120\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NCAM2 directly stabilizes MAP2 protein or acts indirectly through 14-3-3 scaffolding unclear\", \"Relationship between NCAM2-MAP2 complex and MAP2 phosphorylation state not examined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Biophysical measurements showed MAP2's microtubule-binding domain makes microtubules more flexible (lower flexural rigidity) than tau, and MAP2-expressing cells produce more branched protrusions, linking mechanical properties to dendritic branching morphology.\",\n      \"evidence\": \"In vitro hydrodynamic flow teardrop assay for flexural rigidity; EGFP-MAP2 expression in SH-SY5Y cells\",\n      \"pmids\": [\"37258650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MAP2 projection domain contributes to mechanical properties not tested\", \"Mechanism by which reduced stiffness promotes branching remains correlative\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the atomic-resolution structure of MAP2 bound to microtubules and actin, how phosphorylation-site-specific modifications are integrated in vivo to produce distinct morphological outcomes, the full composition and regulation of MAP2 mRNA transport granules, and the physiological significance of MAP2-neurosteroid and MAP2-lipid interactions in mature neural circuits.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of MAP2 on microtubules or actin\", \"No integrative in vivo phosphoproteomics linking specific sites to specific dendritic phenotypes\", \"Neurosteroid receptor function of MAP2 not validated in vivo in behaving animals\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 3, 7, 12, 23, 25, 34]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [7, 19, 25, 26]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [6, 17, 27]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 2, 3, 7, 12, 18, 19, 25, 34]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [14, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 6, 9, 14, 17, 27]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [7, 8, 26, 34]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [4, 9, 27]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [26, 30]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PRKAR2B\",\n      \"CACNA1C\",\n      \"NCAM2\",\n      \"L1CAM\",\n      \"NEFL\",\n      \"STAU2\",\n      \"YWHAG\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"MAP2 is a neuron-enriched microtubule-associated protein that orchestrates dendritic cytoskeletal architecture by promoting microtubule polymerization, nucleation, stabilization, and bundling through a C-terminal repeat domain, while also cross-linking microtubules to neurofilaments and actin filaments [PMID:3142041, PMID:1487506, PMID:3045269, PMID:2115775]. Its microtubule-binding affinity is bidirectionally regulated by phosphorylation: cdc2, MARK, GSK3β, and PKA phosphorylation within or near the repeat domain detach MAP2 from microtubules and redirect it toward actin-rich compartments, whereas NMDA receptor–activated calcineurin-mediated dephosphorylation restores microtubule association [PMID:11029056, PMID:2169265, PMID:8789950, PMID:10542369]. Beyond cytoskeletal regulation, MAP2 functions as an A-kinase anchoring protein (AKAP) that recruits PKA-RIIβ to dendrites—required for cAMP/CREB signaling and contextual fear memory—and directly binds the α1 subunit of L-type Ca²⁺ channels independently of microtubules [PMID:12163474, PMID:12763072, PMID:10514522]. Its mRNA is targeted to dendrites via a 640-nucleotide cis-acting element in the 3′ UTR, enabling local translation, while high-molecular-weight isoforms (MAP2a/b) contain a projection domain that determines inter-microtubule spacing, dendritic morphology, and lipid binding absent from the embryonic MAP2c splice variant [PMID:10516301, PMID:2770869, PMID:8868472].\",\n  \"teleology\": [\n    {\n      \"year\": 1984,\n      \"claim\": \"Establishing MAP2 as a dendrite-specific cytoskeletal protein resolved the question of whether microtubule-associated proteins showed compartmental specificity in neurons, revealing MAP2 localizes to dendrites and postsynaptic densities but not axons.\",\n      \"evidence\": \"Immunocytochemistry and immunoelectron microscopy with monoclonal antibodies on brain tissue\",\n      \"pmids\": [\"6699682\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of dendritic restriction unknown at this stage\", \"Whether MAP2 has functions independent of microtubules at postsynaptic densities was unresolved\"]\n    },\n    {\n      \"year\": 1984,\n      \"claim\": \"Demonstrating that phosphorylation reduces MAP2–microtubule affinity in a dose-dependent manner established phosphorylation as a regulatory switch for MAP2 function, opening the question of which kinases and phosphatases operate in vivo.\",\n      \"evidence\": \"In vitro phosphorylation by co-purifying kinase; taxol-stabilized microtubule binding and polymerization kinetics\",\n      \"pmids\": [\"6146522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the endogenous kinase unknown\", \"In vivo relevance not yet demonstrated\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Mapping the microtubule-binding domain to the C-terminal 18-amino-acid repeats defined the minimal structural unit for MAP2–tubulin interaction and revealed domain architecture shared with tau.\",\n      \"evidence\": \"In vitro translation of MAP2 subcloned fragments followed by microtubule co-purification cycles; cDNA sequencing\",\n      \"pmids\": [\"3142041\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether flanking sequences contribute to binding strength was untested\", \"Structural basis of repeat–tubulin contact unresolved\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Discovery that MAP2 mRNA is dendritically localized provided a mechanism for dendritic MAP2 protein enrichment through local translation, complementing protein-level localization studies and raising the question of what cis-elements direct the mRNA.\",\n      \"evidence\": \"In situ hybridization with specific cDNA probes on developing brain tissue\",\n      \"pmids\": [\"3200318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"cis-acting targeting element not yet identified\", \"Whether local translation is activity-regulated was unknown\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Demonstrating that MAP2 cross-links microtubules to neurofilaments in dendrites expanded its role from microtubule stabilizer to an integrator of the dendritic cytoskeletal network.\",\n      \"evidence\": \"Quick-freeze deep-etch immunoEM in vivo; in vitro reconstitution with neurofilament L protein\",\n      \"pmids\": [\"3045269\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding site on neurofilament L not mapped\", \"Regulation of cross-linking activity unknown\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Identification of the MAP2c splice variant lacking 1,342 aa of the projection domain, and demonstration that high-molecular-weight MAP2a/b but not MAP2c mRNA is dendritically targeted, linked alternative splicing to both isoform-specific architecture and mRNA localization.\",\n      \"evidence\": \"cDNA cloning/sequencing; in situ hybridization for MAP2c mRNA; EM of reconstituted microtubules\",\n      \"pmids\": [\"2770869\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Developmental regulation of splicing switch uncharacterized\", \"Projection domain contribution to inter-microtubule spacing not quantified\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Microinjection tracking showed MAP2 protein enters both axons and dendrites but is selectively retained in dendrites via cytoskeletal binding, establishing differential retention rather than sorting as the compartmentalization mechanism.\",\n      \"evidence\": \"Microinjection of biotin-labeled MAP2 into spinal cord neurons; immunoEM with detergent extraction\",\n      \"pmids\": [\"2657741\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What makes dendritic microtubules preferentially bind MAP2 was not determined\", \"Whether phosphorylation state influences compartmental retention was untested\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"The tubulin-binding repeats were shown to also bind actin, revealing MAP2 as a bifunctional cytoskeletal linker and raising the question of how microtubule versus actin association is regulated.\",\n      \"evidence\": \"Affinity chromatography of G-actin on synthetic peptide; F-actin co-sedimentation\",\n      \"pmids\": [\"2115775\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether microtubule and actin binding are mutually exclusive was unclear\", \"In vivo significance of actin binding not demonstrated\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"NMDA receptor activation was shown to rapidly dephosphorylate MAP2 via calcineurin, linking synaptic activity to microtubule regulation and identifying the first physiological signal controlling MAP2 phosphorylation state.\",\n      \"evidence\": \"32P-orthophosphate labeling of hippocampal slices; NMDA antagonist pharmacology\",\n      \"pmids\": [\"2169265\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphorylation sites dephosphorylated by calcineurin not mapped\", \"Functional consequences for microtubule stability not directly measured\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Gain-of-function expression in non-neuronal cells proved MAP2 is sufficient to stabilize microtubules against depolymerizing agents, bundle them independently of the MTOC, and impart structural stiffness—core functions for dendritic architecture.\",\n      \"evidence\": \"MAP2/MAP2c cDNA transfection into fibroblasts; drug resistance assays; acetylated tubulin staining; immunofluorescence\",\n      \"pmids\": [\"1487506\", \"1338311\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How bundling is coordinated with other dendritic MAPs in vivo unknown\", \"Whether MAP2 stiffness is modulated by post-translational modifications untested\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Photoactivation studies revealed MAP2c-bundled microtubules have extremely low internal tubulin exchange yet retain assembly-competent ends, explaining how MAP2 preserves stable dendritic microtubule cores while permitting dynamic growth.\",\n      \"evidence\": \"Photoactivation of caged fluorescein-tubulin in MAP2c-transfected fibroblasts; biotin-tubulin microinjection\",\n      \"pmids\": [\"8421058\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this dynamic end assembly is regulated by MAP2 phosphorylation was not tested\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Systematic deletion mutagenesis established that efficient microtubule binding requires the repeat domain plus flanking proline-rich sequences, and that binding strength correlates with bundling capacity and process outgrowth.\",\n      \"evidence\": \"Series of MAP2c deletion mutants transfected into non-neuronal cells; immunofluorescence and process outgrowth assays\",\n      \"pmids\": [\"7699010\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of flanking region contribution unresolved\", \"Whether post-translational modifications of flanking regions modulate binding untested\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Biphasic glutamate-dependent phosphoregulation was mapped: metabotropic receptors activate CaMKII/PKC to transiently phosphorylate MAP2, while NMDA receptors activate calcineurin for sustained dephosphorylation, establishing a synaptic activity-dependent phosphorylation code that switches MAP2 between microtubule and actin association.\",\n      \"evidence\": \"32P-labeling in neurons; pharmacological dissection with receptor agonists/antagonists and kinase/phosphatase inhibitors\",\n      \"pmids\": [\"8789950\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphosites responsible for the actin switch not identified\", \"Whether the biphasic response occurs at individual synapses unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Distinct kinase-specific functional consequences were resolved: cdc2 phosphorylation abolishes both stabilizing and nucleating activities, while PKA phosphorylation selectively eliminates nucleation without affecting stabilization, demonstrating that different phosphorylation patterns produce distinct functional outcomes.\",\n      \"evidence\": \"In vitro phosphorylation by purified PKA and cdc2; dark-field single-microtubule visualization\",\n      \"pmids\": [\"9376363\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of cdc2-mediated MAP2 regulation in postmitotic neurons unclear\", \"Combinatorial effects of multiple kinases untested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of MAP2B as an AKAP that directly binds L-type Ca²⁺ channel α1 subunits and recruits PKA to postsynaptic sites revealed a scaffolding function independent of microtubule binding, expanding MAP2's role to signaling complex assembly.\",\n      \"evidence\": \"Reciprocal Co-IP from brain; direct protein overlay binding; nocodazole control for microtubule independence\",\n      \"pmids\": [\"10514522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether channel-MAP2-PKA complex formation is activity-regulated unknown\", \"Stoichiometry of the complex not determined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"MARK kinases were identified as physiological kinases that phosphorylate KXGS motifs in the microtubule-binding domain, causing MAP2 detachment and microtubule destabilization in cells.\",\n      \"evidence\": \"Inducible MARK1/MARK2 expression in CHO cells; microtubule stability and immunofluorescence assays\",\n      \"pmids\": [\"10542369\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"MARK regulation in neurons not addressed\", \"Whether MARK acts on MAP2 at synapses unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"A 640-nt cis-acting dendritic targeting element in the 3′ UTR was shown to be necessary and sufficient for MAP2 mRNA dendritic localization, resolving the long-standing question of what directs MAP2 mRNA to dendrites.\",\n      \"evidence\": \"Chimeric mRNA reporters in hippocampal and sympathetic neurons; in situ hybridization\",\n      \"pmids\": [\"10516301\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting factors recognizing the DTE not identified\", \"Whether the DTE is activity-regulated unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Phosphomimetic mutations at KXGS motifs demonstrated that phosphorylation actively redirects MAP2 from microtubules to actin-rich membrane ruffles, establishing the molecular basis for phosphorylation-dependent cytoskeletal switching.\",\n      \"evidence\": \"Site-directed KXGS-to-Glu mutagenesis in HeLa cells; immunofluorescence; biochemical fractionation\",\n      \"pmids\": [\"11029056\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this switch occurs dynamically at synapses in neurons not shown\", \"Actin-binding surface versus microtubule-binding surface overlap not structurally resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"MAP2 knockout mice revealed essential roles in dendritic elongation, microtubule density maintenance, and PKA/CREB signaling in dendrites, establishing MAP2 as both a structural and signaling scaffold in vivo.\",\n      \"evidence\": \"MAP2-deficient mice; microtubule density measurement; PKA subunit and phospho-CREB assays in cultured neurons\",\n      \"pmids\": [\"12163474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Behavioral consequences of full MAP2 knockout not reported in this study\", \"Compensatory changes by tau or MAP1B not assessed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Targeted deletion of the N-terminal PKA-anchoring domain showed that MAP2's AKAP function is specifically required for contextual fear memory, dissociating the signaling role from microtubule stabilization in a behavioral paradigm.\",\n      \"evidence\": \"N-terminal deletion mice by homologous recombination; fear conditioning behavioral tests; phosphorylation analysis\",\n      \"pmids\": [\"12763072\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream PKA substrates mediating contextual memory not identified\", \"Whether other AKAPs compensate partially unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Quantitative binding of the neurosteroid DHEA to the MAP2c N-terminus (Ka ~2.7×10⁷ M⁻¹) identified MAP2 as a direct neurosteroid receptor, a function previously unrecognized for a cytoskeletal protein.\",\n      \"evidence\": \"Isothermal titration calorimetry; tryptic digestion and mass spectrometry domain mapping\",\n      \"pmids\": [\"12775713\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of neurosteroid–MAP2 interaction not demonstrated in this study\", \"Whether DHEA binding alters MAP2 microtubule affinity untested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"RNAi knockdown confirmed MAP2 is required for pregnenolone-stimulated neurite extension, validating MAP2 as a functional neurosteroid receptor that couples steroid binding to microtubule polymerization and neurite growth.\",\n      \"evidence\": \"MAP2 RNAi in PC12 cells; neurite outgrowth with PREG/MePREG; nocodazole protection assay\",\n      \"pmids\": [\"16537405\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Binding site for PREG on MAP2 not mapped at residue resolution\", \"Whether neurosteroid regulation of MAP2 occurs in vivo in adult brain unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Single-molecule RNA imaging revealed MAP2 mRNA travels in small ribonucleoprotein particles whose composition is regulated by synaptic activity and Staufen 2, linking activity-dependent translational control to MAP2 mRNA transport.\",\n      \"evidence\": \"Single-molecule FISH; Staufen 2 manipulation; synaptic activity modulation\",\n      \"pmids\": [\"21869818\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Staufen 2 directly binds the MAP2 3′ UTR DTE not shown\", \"Translational output from individual RNPs not measured\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"NMR and cryo-EM structural analysis established that MAP2c is intrinsically disordered in solution but adopts defined conformations upon microtubule and F-actin binding, with transient local structural motifs (molecular recognition elements) marking functional interaction sites.\",\n      \"evidence\": \"NMR conformational analysis; cryo-EM; comparison of free versus complex-bound states\",\n      \"pmids\": [\"30884818\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"High-resolution structure of MAP2 bound to microtubules not achieved\", \"How phosphorylation alters these transient structures at atomic resolution unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Biophysical measurements revealed MAP2 makes microtubules more flexible than tau does, correlating with increased process branching in neuronal cells, providing a mechanical basis for MAP2's role in dendritic (branched) versus tau's role in axonal (linear) architecture.\",\n      \"evidence\": \"Fluorescence microscopy of microtubules in hydrodynamic flow; teardrop flexural rigidity analysis; SH-SY5Y transfection\",\n      \"pmids\": [\"37258650\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether flexibility differences arise from distinct binding geometries or stoichiometries not resolved\", \"In vivo measurement of microtubule flexural rigidity in dendrites versus axons not performed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structural model of full-length MAP2 bound to microtubules is lacking, and how the multiple regulatory phosphorylation inputs are integrated at individual synapses to dynamically control MAP2 cytoskeletal switching, AKAP scaffolding, and neurosteroid reception remains an open question.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution structure of MAP2–microtubule complex\", \"Combinatorial phosphorylation code not decoded in vivo\", \"Compensation between MAP2, tau, and MAP1B in dendritic function not systematically addressed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 4, 9, 13, 14, 18, 24, 34, 35]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [3, 4, 13, 18, 26]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [5, 10, 33]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 3, 4, 9, 13, 14, 18, 20, 24, 35]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 5, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 6, 8, 10, 33]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 5, 33]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [4, 18, 26, 35]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PRKAR2B\",\n      \"CACNA1C\",\n      \"NEFL\",\n      \"MARK1\",\n      \"MARK2\",\n      \"GSK3B\",\n      \"NCAM2\",\n      \"L1CAM\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}